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Abstract

Optically active alcohols are useful building blocks for the synthesis of
biologically active' and structurally interesting compounds.2 These types of compounds
have been prepared by asymmetric hydrogenation of olefins (eq. I), and enantioselective
hydrogenation of ketones and alpha or beta-keto esters using gaseous hydrogen with
homogeneous and heterogeneous catalyst systems.3
Eq. 1
(S)-BinapRu(oA~)~
Geraniol

(R)-Citronellol
100% yield, 96.99% ee

In addition to straightforward asymmetric hydrogenation, which results in high
enantioselectivity, there has been recent interest in the preparation of these compounds
using asymmetric transfer hydrogenation (ATH) where the hydrogen source comes from a
solvent.
This method has been extensively used for aldehydes and ketones4 because of the
favorable properties of the hydrogen donor as well as the operational simplicity. Recent
work in our group has shown that this reaction is amenable to a new class of substrates,
allylic alcohols (eq. 2). Geraniol was converted to citronellol in 90 - 95 % yield and 95 -

I

Hashiguchi, S.; Fujii, A,; Takehara, 1.; Ikariya, T.; Noyori, R. J. Am Chem. Soc. 1995, 117,7562-7563.
Masumma, K.; Hashiguchi, S.; Ikariya, T.; Noyory, R. J. Am. Chem, Soc. 1997, 119,8738-8739.
Noyory, R. Asymmetric Catalysis in Organic synthesis, Wiley: New York, 1994.
4
a) Iyer, S.; Varghese, J.P. Chem. Soc., Chem, Commun. 1995,465; b) Ahn, K. H.; Ham, C.; Kim, S. K.;
Cho, C. J . Org. C k m . 1997,62,7047; c) Yamada, I.; Noyori, R. Organic LRtters 2000,2 (22), 3425; d)
Wills, M.;Palmer, M.; Smith, A.; Kenny, J.; Walsgrove, T. Molecules2000,5,4.
2

98 % ee (R) using isopropyl alcohol as the solventmydrogen source and an in situ
prepared catalyst Ru-(S)-tolBWAP.
Eq. 2

uoH
Ru-(S)-tolBWAP_
0.01 M P A soh.
2 eq KOHRu
SIC 1011

Geraniol

(R)-Citronellol
90-95% yield
95-98% ee

An investigation on the mechanism of this ATH reaction was conducted. The
results from the deuterated experiments lead us to propose that the olefin isomerizes to
the en01 followed by a transfer hydrogenation reaction (eq. 3). The isomerization takes
place by a metal-assisted 19-hydrogen shift via a z-ally1 i d

nediate. The transfer

hydrogenation step is in good agreement with the mechanisitic

ps found in the well-

studied transfer hydrogenation of carbonyl groups.
Eq. 3
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CHAPTER 1: A REVIEW OF ASYMMETRIC HYDROGENATION AND
ASYMMETRIC TRANSFER HYDROGENATION
1.1 Introduction
Asymmetric hydrogenation is an important tool in synthetic organic chemistry. It
has dramatically changed the procedures of chemical synthesis since its modest
beginnings in the 1960s. It all began by the discovery of Wilkinson that
triphenylphosphinelRh complexes could catalyze hydrogenation of olefins in so~ution.~
The field really got underway when Knowles and Homer reported the first examples of
asymmetric hydrogenation of prochiual olefins with chiral phosphine/Rh complexes in
1968.~Asymmetric catalysis became so important in organic synthesis that three
researchers in this area were awarded with the 2001 Nobel Prize in chemi~try,~
which
was shared among William S. Knowles and Ryoji Noyori for their work on catalytic
asymmetric hydrogenation reactions and Barry K. Sharpless for his work on catalytic
asymmetric epoxidation reactions. Today, about half of the commercial drugs in use are
chira17 and in 2005, the worldwide sales of single-enantiomer drugs reached 225 billion
US dollars based on estimates from Technology Catalysts International (TCI).' In this
chapter, the origin, the use and the mechanism of various types of homogeneous
asymmetric reductions will be reviewed.

1.2 Overview of Asymmetric Hydrogenation
1.2.1 Wilkinson's Catalysts
5

6

Knowles, W. S.; Noyori, R. Acc. Chem. Res. 2007,40, 1238.
http://nobelprize.org/nobeIIprizeslche~sl

' Noyori, R. Angew. Chem. In!. Ed. 2002,41,2008.

The first efficient catalysts in the homogeneous hydrogenation of unsaturated
compounds were reported by Geoffrey Wilkinson in 1966 with the discovery of its

tris(triphenylphosphine)halogenorhodium( complexes.9 Previous catalysts, particularly
the cobalt(Q-cyanide system, had limited use as they were efficient only in the
reduction of conjugated double bonds (butadiene, a$-unsaturated acids and aldehydes),
but not in isolated ethylenic linkages.9

Scheme 1.1: Preparation of Wilkinson's TriphenylphosphineiRh Catalyst Complexes.
RhX3(H20)3 + CH3CH20H + 3 PPh3 -+ RhX(PPh3)3+ CH3CHO + 2 HC1+ 3 H20
(X = C1, Br, I)

The Wilkinson's catalysts were prepared by the reaction of excess
triphenylphosphine with rhodium(III) halide in ethanol (Scheme 1.1). In homogeneous
solution, the tris(tripheny1phosphine) complexes were reported to be exceedingly active
catalysts for rapid homogeneous hydrogenation of unsaturated compounds containing
isolated olefinic and acetylenic linkages!
The mechanism (Figure 1.1) involves the initial dissociation of one or two
triphenylphosphine ligands to give 14 or 12-electron complexes, respectively. Oxidative
addition of hydrogen to the metal center generates the 16 electron Rh complex.
Subsequent insertion of the olefin follow by reductive elimination results in the formation
of the reduced product.'0

http://www.pharmatech.com/
Osborn, J. A,; Jardine, F. H.; Young, J. F.; Wilkinson, G. J. ChemSoc. (A) 1966,171 1 .
10
James, B . R. Homogeneous Hydrogenation, John Wiley & Sons: New York, 1973.

9

Figure
1.1: The
Mechanism
of
Hydrogenation
Tris(tripheny1phosphine)-chlororhodium(I) Catalyst.

with

Wilkinson's

1.2.2 Asyrnrnetrk Hydrogenation with Chiral Phosphine Ligands
The rust examples of catalytic asymmetric hydrogenation were reported by
Knowles and Homer in 1968 with the synthesis of their chiral phosphinelrhodium
complexes." Knowles reported the hydrogenation of a-phenylacrylic acid with 0.15 mole
% of RhC13L3 (L = (-)-methylpropyl-phenylphosphine), which gave 2-phenylpropanoic

acid in 15% ee at 60 "C, and the hydrogenation of itaconic acid to succinic acid in 3% ee
at 25 and 60 OC (Scheme 1.2)." a That same year, Homer reported that a-ethylstyrene and

a-methoxystyrene could be hydrogenated to (S)-(+)-2-phenylbutane in 7 - 8 % ee and

(R)-(+)-1-methoxy-1-phenylethane in 3

-

4 % ee, respectively, in the presence of 0.5

mole % of the same chiral ligand at normal pressure and room temperature."

Scheme 1.2: Asymmetric Hydrogenation with Chiral Phosphine Ligands.
COOH

RhC 3L3

COOH

*&
/

"2

MeOH 6C 'C

15% ee

RhC 3L3

COOH

HOOCA
* HOOCA
MeOH 256C 'C
"2

Scheme 1.3: Asymmetric Hydrogenation with Chiral PhosphineIRh Catalysts.
R4

0.05% [Rh(l,5-cyclo-octadiene)(CI)L]
H2, 10-55psi
HOOC'NHC0R5
Alcoholic solvent, 25-50OC
-80% ee
R4 = H, Ph, M ~ O ~ - ( O H ) - C ~MHe~0, 4 (Ac0)-CsH3
R5 = Ph, Me

1 1
a*;;:e

R' = eanisyl, manisyl, Me, Cyclohexyl
R~ = Me, Ph, cyclohexyl
,
R3 = Ph, PI", ~ r ' Me

I1

CAMP

a) Knowles, W. S.; Sabacky, M. 1.3. Chem. Soc., Chem. Commun. 1968, 1445. b) Homer, L.; Siegel, H.
Angew. Chem. Int. Ed. 1968, 7, 942.

A few years later, Knowles and coworkers synthesized a new series of chiral
phosphine ligands, which gave moderate to good enantiomeric e ~ c e s s . 'This
~ resulted in
the discovery of o-anisylmethylcyclohexylphosphine(CAMP), giving 80% enantiomeric
excess (Scheme 1.3).
Several a-acylaminoacrylic acids were hydrogenated to their corresponding aamino acids using 0.05 mole % of the rhodium catalysts under 10 - 55 psi of hydrogen at
25 - 50 "C. Of particular interest were the high optical purities obtained with oanisylmethylcyclohexylphosphine (CAMP) when applied to various acylphenylalanine

substrates. These yields ranging from 85 - 90 % show that almost complete
stereospecificity was achieved considering that the phosphine ligand was only 95% ee.
On the other hand, the lower optical yields, 4 0 % ee, indicate that the ligand is not the
only factor influencing the outcome of the product.
The o-anisylmethylcyclohexylphosphine (CAMP) catalyst gained its major
importance when it was applied to the preparation of commercial drug L-DOPA, an antiParkinson drug (Scheme 1.4).13
Several catalysts (Figure 1.2) were screened in the hydrogenation step, the key
step in L-DOPA synthesis, and the best enantiomeric excess (88%) was then obtained
with CAMP, which resulted in an isolated yield of about 70%. This was the first time
enzymatic-like selectivity was obtained with a man-made catalyst.13Later, the ligand was
replaced with 1,2-bis(pheny1orthoanisylphosphino)ethane (DIPAMP), which gave 95% ee
and an isolated yield of 75 - 80 %.

12

Knowles, W. S.; Sabacky, M. J.; Vineyard, B. D. Chem. Commun. 1972,lO.

l3

Knowles, W . S . Angew. Chem. Int. Ed. 2002,41,1998.
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Scheme 1.4: The Use of CAMP in L-DOPA Synthesis.

HO*

Ac~O

3
FOOH

+

H3C0

NHAc

H3C0

NHAc

I

H2

*

[Rh(CAMP)]

NHAc
H3C0

/

HO

L-DOPA

Figure 1.2: Phosphine Ligands Screened in the Asymmetric Hydrogenation Step in
L-DOPA Synthesis.
Entry

Ligand

% ee

1.2.3 Asymmetric Hydrogenation with Cz-Chiral Biphosphine Ligands
The field of asymmetric hydrogenation really got underway with the discovery of
the first active Cz-chiral biphosphine ligand 4,5-Bis-[(diphenylphosphanyl)-methyl]-2,2dimethyl-[1,3]dioxolane (DIOP).I4 Previous example of C2-chiral phosphine ligand

(Entry 1, Figure 1.2) resulted in no enantiosele~tivit~.'~
It was believed that to get
enantioselectivity, the chirality needed to be directly on the phosphorous atom, but
Kagan's discovery of the DIOP ligand has proven otherwise.
The active catalyst was prepared in situ by adding two equivalents of DIOP to a
benzene-ethanol solution of [Rh-(cyclooctene)2C1]2. The resulting solution catalyzed the
hydrogenation of a$-unsaturated carboxylic acids in 95% yields and 63 - 72 % ee
(Scheme 1.5).

Scheme 1.5: Asymmetric Hydrogenation with DIOP.
R'

R2

>=(COOH
H

[Rh(l)(L)Clsolrent], 3.3 mol %
H2
Et3N, Benzene-EtOH

HF2

R'

H

COOH

95% Yield. 63-72% ee

(1) R' = H, R 2 = Ph
(2) R1=Ph, R 2 = NHAc
(3) R1 = H, R2 = NHCOCH2Ph

14

Dang, T. P.; Kagan, H. B. Chem. Commun. 1971,481.
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These results have generated a lot of interest and for the next decade many
efficient C2-chiral biphosphine ligands were discovered. However, these ligands were
useful only on enamides, en01 esters and carboxylic acids (Figure 1.3).13 Other
compounds like a-arylacrylic acids and unfunctionalized olefins worked poorly or were
simply inactive.

Figure 1.3: The Use of Diphosphine Ligands in Asymmetric Hydrogenation.

Chiraphos
(Bosnich)

enamides
BPPM
(Achiwa)

(Rhone-Poulene)

(kh

,40
o=(

CH3
enol eters
PNNP
(Giogo)
COOH

BPPFA
(Kumada)
carboxylic acids

Scheme 1.6: Asymmetric Hydrogenation of Functionalized Olefins with Ru-BINAP.

P(c6H5)2
P(C6H5)2
S-BINAP

4 p 0 (NHCHO
0cH3)2

NHCHO

It wasn't until 1980 - 1986 that the scope of asymmetric hydrogenation was
expanded with the discovery of ruthenium 2,T-bis(dipheny1phosphino)-1,l'-binaphthyl
(RulSINAP) complexes. This axially di-symmetric Cz biphosphine ligand coupled with
ruthenium allows asymmetric hydrogenation of a wide range of functionalized olefins
including a-arylacrylic acids, a$- and P,y-unsaturated carboxylic acids, ally1 and homo-

allylic

alcohols,

2-acyl-benzylidene-1,2,3,4-tetrahydroisoquinolines, a-

and

P-

aminoacids, as well as a-amino phosphonic acids (Scheme l.6).I5
The Ru-BINAP complexes were also useful in the asymmetric hydrogenation of a
wide range of functionalized ketones, wherein coordination of nitrogen, oxygen, and
halogen groups near the carbonyl group directed the reactivity and stereoselectivity of the
product (Scheme 1.7). The reactions are normally conducted in alcoholic solvents under 4

- 100 atm hydrogen pressure at room temperature to give the corresponding alcohols in 90
- 100 % ee.I5
Scheme 1.7: Asymmetric Hydrogenation of Functionalized Ketones with Ru-BINAP.

I

15

Ni, R.; Ohkuma, T . Angew. Chem. Int. Ed. 2001,40,40.
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S-BINAP

The 2,Z-bis(dipheny1phosphino)-1,l'-binaphthyl(BINAP) worked well with Rh
(I) and Ru ( Q but gave opposite enantiomers. This is due to the operation of different

catalytic cycles, a dihydride mechanism for Rh (I) versus a monohydride pathway for Ru
( Q . ~The dihydride mechanism for Rh (I) (similar to Figure 1.1) proceeds via oxidative
addition of Hz,to diastereomeric Rh-substrate chelate complexes, followed by stepwise
transfer of the hydrides to the coordinated olefin; which involves a +1/+3 redox process.

In contrast to the monohydride pathway for Ru(II), the ruthenium center remains in the +2
oxidation state throughout the catalytic cycle. Figure 1.4 illustrates the mechanism of
RU(II)BINAP.'~
The reaction has been shown to proceed via a ruthenium intermediate 2 formed by
heterolysis of Hz by the Ru complex 1. Interaction of 2 with the P-keto ester forms
complex 3. Protonation of the keto oxygen follow by hydride transfer generates the Ruhydroxy ester 4, which interacts with a solvent molecule to release the chiral P-hydroxy
ester. The cationic ruthenium 5 reacts with another hydrogen molecule to regenerate 2,
which reenters the catalytic cycle.
The Ru-BINAP complexes have some important applications in the synthesis of
many commercial

compound^.^ For example, the anti-inflammatory drug Naproxen can

be obtained in 97 % ee from the corresponding a-aryl-acrylic acid using this catalyst.'6
Similarly, citronellol can be obtained in 96 - 98 % ee from geraniol or nerol without over
reduction to the dihydrocitronellol'7 (Scheme 1.8).

16

a) Ohta, T.; Takaya, H.; Kitamura, M.; Nagai. K.; Noyori, R. J. Org. Chem. 1987,52,3174; b) Vineyard
B.; Knowles, W.; Sabacky, M.; Bachman, G.;Weinkauff, D. J. Am. Chem. Soc. 1977,99,5946.
17
Takaya, H.; Ohta, T.; Sayo, N.; Kumobayashi, H.; Akutagawa, S.; Inoue, S.; Kasahara, I.;
Noyori, R. J. Am. Chem. Soc. 1987,109,1596.

Figure 1.4: The Mechanism of Ru(II)BINAP Catalyzed Hydrogenation of P-Keto Esters.
RuC12(BINAP)(solvent)2

-

Hz

- HCI

1

RUHCI(BINAP)(SO~V~~~)~
2

solvent

3

R
[RuHCl(BlNAP)(~olvent)~]
2
4

solvent

Hz

5

Scheme 1.8:Application of Ru-BINAP in Commercial Syntheses.

> 30 atm. Hz
MeOH
-

geraniol

A
(R)citronellol
99% yield
96-98% ee

135 atm. Hz
MeOH

The Ru-BINAP system was considered a major breakthrough for extending the
scope of asymmetric hydrogenation to a variety of functionalized olefins and ketones.
None of the previous chiral ligands (mono- and bi-phosphine) offered this kind of
diversity. The Ru-BINAP system is thought to come close as a universal asymmetric
hydrogenation catalyst. However, this catalyst system was not efficient in the
hydrogenation of non-functionalized ketones, particularly with a ~ e t o ~ h e n o n e . ~

1.2.4 Asymmetric Hydrogenation with BZNAP/Diamine Ligands

In 1995, the hydrogenation of simple ketones became possible with the discovery

of BINAPIdiamine-ruthenium complexes. These catalysts, particularly RuClz(xy1BINAP)-DAIPEN, were very efficient in the presence of a strong base (KOH, KOtBu) in
the enantioselective hydrogenation of a range of aromatic, heteroaromatic, and olefinic
ketones in i s ~ ~ r o ~ a n oFor
l . ' ~ example, acetophenone and its derivatives can be
hydrogenated to the corresponding alcohols in 94 - 96 % ee. In addition, a$-unsaturated
ketones can now be hydrogenated in the presence of a weaker base (K2CO3)to give the
corresponding chiral allylic alcohols (Scheme 1.9).Is
The mechanism of the BINAPIdiamine-ruthenium reduction is shown to be
different from the mine-free BINAP reduction. The high reactivity and chemoselectivity
of the BINAPIdiamine system is due to a bifunctional mechanism (Figure 1.5).7

Scheme 1.9: Asymmetric Hydrogenation of Simple Ketones with Ru-BINAP/Diamine.
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T.; lkaryaT.; Noyori, R. J. Am. Chem. Soc. 1998,120,13529. b) Ohkuma,T.; Ooka, H.; Ikariya, T.;
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(3)

Figure 1.5: a) Non-classical Metal-Ligand Bifunctional Mechanism and Conventional
[2+2] Mechanism. b) Catalytic Cycle of Hydrogenation of Ketones with
Ru(QBEVAP/Diarnine.
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Figure 1.5 (a) shows the six-membered ring intermediate describing a Ru hydride
species possessing an NH2 ligand, whose protons (Ru-H and N-H) are stimultaneously
transferred to the C=O linkage, without direct coordination of the carhonyl substrate to
the metaL7 Figure 1.5 (b) shows a more detailed mechanism. The 18-electron ruthenium
hydride 2 reacts with the carbonyl group via the six-membered ring intermediate shown

in Figure 1.5 (a) to give the product alcohol and the 16-electron complex 3. The high
turnover efficiency of this catalyst system is believed to originate from the alternating
charge arrangement of HS- RU"

N'- H"

on the six-membered ring intermediate.

Therefore, the hydride at the ruthenium center has sufficient nucleophilicity and the NH
hydrogen-bonding ability activate the carbonyl substrate. The ruthenium complex 3 reacts
with Hz in the presence of base and a protic solvent to regenerate 2, which goes back to
the catalytic cycle via complex 4 and complex s . ~Is'

Figure 1.6: Application of BINAP/Diamine-Ruthenium Complexes in Commercial
Compounds.

denopamine hydrochloride
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fluoxetine hydrochloride
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The BINAPIdiamine-ruthenium complexes have many industrial applications. For
example, (R)-neobenodine, a PI-receptor agonist, can be synthesized by doing asymmetric
hydrogenation of o-bromo-p7-methylbenzophenoneas a key step.I9 Other applications
include (R)-denopamine, another pi-receptor agonist, the antidepressant (R)-fluoxetine,
the antipsychotic BMS 181100, and (S)-duloxetine, a potent inhibitor of serotonin and
norepinephrine (Figure 1.6).'

1.2.5 Summary of Asymmetric Hydrogenation
Asymmetric hydrogenation is an important tool in organic synthesis. Since the
discovery of the first chiral phospinem complexes in the late 1960s, this field in organic
synthesis has enabled efficient synthetic routes, including the asymmetric synthesis of
many medicinally and industrially important compounds. Over the years, asymmetric
reduction has expanded to various types of substrates, which include functionalized
olefins, functionalized ketones and simple ketones. These transformations became
possible with the discovery of more reactive and chemoselective ligandcatalyst systems.

I

The chiral mono-phosphine ligands/modium catalyst systems @gure 1.2),
particularly CAMP, gave moderate enantioselectivity (-80%) in the asymmetric reduction

of unsaturated amino acids and carboxylic acids. Later, the enantioselectivity was
increased to up to 99% ee with the discovery of the diphosphine ligands (Figure 1.3). The
asymmetric reduction of a broader range of olefins (Scheme 1.6) and functionalized
ketones (Scheme 1.7) became possible with the discovery of the BINAPIruthenium
catalyst system. Today, even the long time challenging a-phenylacrylic acid and its
- -
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derivatives as well as various simple ketones (Scheme 1.9) can be hydrogenated in high
yield and good enantiomeric excess (90 - 96 %) with the BJNAPldiamine ruthenium
complexes.
Despite the high reactivity and chemoselectivity obtained with these catalyst
systems, safer procedures are desired among organic chemists. Most asymmetric
hydrogenations are conducted under high pressure, thus, special equipment is required.
An alternate procedure is Asymmetric Transfer Hydrogenation (ATH), which eliminates
the need for high pressure vessels. An overview on ATH follows below.

1.3 Overview of Asymmetric Transfer Hydrogenation
Asymmetric transfer hydrogenation is also a well studied area in organic
chemistry.20 It is a convenient method to reduce carbonyls, imines and activated olefins
without the use of hydrogen pressure or hazardous reducing

In recent years,

asymmetric transfer hydrogenation has been classified second to gaseous hydrogenation
among the methodologies suitable for this

This method is being extensively

studied because of the low cost and favorable properties of the hydrogen donor as well as
operational simplicity. Transfer hydrogenation can take place under two major types of
mechanisms: metal-template concerted process [Meenvein-Pomdorf-Verley (MPV)
reduction] and metal hydride mediated process (hydridic reduction).20aAn overview of
these two processes is given in the following section.

20

a) Gladiali, S.; Alberico, E. Chem Soc. Rev. 2006,35,226; b) Hashiguchi, S.; Fujii, A,; Takeham, L.;
Akayira, T.; Noyon, R J. Am. Chem. Soc. 1995,117,7562; c) Mizushima, E.; Yamaguchi, M.: Yamagishi,
T. Chem. Lett. 1997,237; d) Palmer, M.; Walsgrove, T.; Wills, M. J. Org. Chem. 1997,62,5226.

1.3.1 Meenvein-Ponndorf-Verley (MPV)Reduction
The first example of transfer hydrogenation is dated back to 1925 when Meenvein
and Schmidt performed the hydrogenation of an aldehyde with aluminum ethoxide in
ethanol?' The same year, Verley reported the reduction of butyraldehyde using the same
aluminum ethoxide in the presence of geraniol as a hydrogen donor.22 A year later, 1926,
Ponndorf extended the scope to the reduction to ketones with aluminum isopropoxide in
isopropanol (Scheme 1.10)?' A major drawback of these types of reductions is that a
stoichiometric amount of the metal catalyst is required.

Scheme 1.10: Transfer Hydrogenation with Metal Alkoxide Catalysts.
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The mechanism of this reaction, known as MPV mechanism, proceeds through a
concerted six-membered ring transition state (Figure 1.7).24 The alcohol reactant
coordinates to the metal to form 7. The carbonyl is activated upon coordination to 7 to
form 8, which undergoes rearrangement to form 10 via the six membered-ring
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Meenvein, H.; Schmidt, R. Liebigs Ann. Chem. 1925,444,221.
Verley, A. Bull. Soc. Chim Fr. 1925.37.537.
Ponndorf, W. Angew. Chem. 1926,39,138.
Graauw, C. F. de; Peter, 1.A.; Bekkum, H. V.; Huskens, J. Synthesis 1994,1M17.

intermediate 9. Both the carbonyl compound and the reducing alcohol are bound to the
metal via the six-membered ring intermediate and the reduction occurs without the
formation of any metal hydride.

Figure 1.7: Meenvein-Ponndorf-Verley (MPV) Mechanism.

An enadoselective example of the Meenvein-Ponndorf-Verley (MPV) type of
reduction was reported in 1993 by David ~vans.2' Following Kagand's lead in his C2
chiral backbone catalyst,I4 chiral samarium(IQ was able to reduce carbonyl groups in
high enantioselectivity via transfer hydrogenation using the MPV mechanism. Several
aryl ketones were converted to their corresponding alcohols in high enantiomeric excess
when 5 mole % of the samarium catalyst was used in the presence of isopropyl alcohol as
hydrogen donor at ambient temperatures (Scheme 1.1

Scheme 1.11: Transfer Hydrogenation with Chiral Samarium Catalyst.
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Unlike the previous stoichiometric examples with aluminum alkoxides, this MPV
reduction is catalytic in samarium. However, the samarium catalyst seems to have a
special affinity for isopropyl alcohol as the hydrogen source; other alcohols such as 3pentanol, cyclopentanol, or benzhydrol were ineffective.

1.3.2 Transfer Hydrogenation via MetaLHydride Mediated Mechanism
The second category of transfer hydrogenation involves the formation of a metal
hydride by interaction of the hydrogen donor with the catalyst, which subsequently
transfers the hydride to the ~ubstrate.'~This mechanism is typical for transition metals
[Ru (E), Rh (I), Ir(I)] and depending on the metal, a mono or dihydride metal species may
be involved. The most popular hydrogen donors include formic acidltriethylamine and

isopropyl alcohol (PA). During the process of transfer hydrogenation with P A , the P A
oxidizes to acetone, which also competes for hydrogen and as a result makes transfer
hydrogenation a reversible process.20a The equilibrium of the reaction can be shifted
toward the desired product by using P A as the reaction solvent.

Scheme 1.12: Transfer Hydrogenation with Iridium-Hydride Catalyst.
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Early examples of transition metal catalyzed transfer hydrogenation were reported
by Henbest in the 1960s. 27 For example, the carbon-carbon double bond in
benzylideneacetophenone and related compounds was reduced with 5 mole % of the
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Backvall, J. E. J. Organomer. Chem. 2002,652,105.
Samec, J. S. M.; Backvall, J. E.; Anderson, P. G.; Brandt, B. Chem. Soc. Rev. 2006,35, 237.
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acidic iridium catalyst in boiling isopropyl alcohol (PA) (Scheme 1.12).~'The metal
hydride HIrCl~(Me2S03)~
was believed to be generated from an acidic solution of iridium

tetrachloride/dimethylsulfoxidein boiling IPA.
In 1991, metal-hydride transfer hydrogenation was optimized with the addition of
a strong base. Aliphatic and aromatic ketones were reduced with 0.1 mole % of
RuC12(PPh3)3 and 2.4 mole % of sodium hydroxide in isopropyl alcohol at 82 "C (Scheme
1.13):~ The reactions remained in equilibrium giving up to 89% conversion. However,
distillation of the by-product acetone resulted in full conversion of the

substrate^.^^ This

was an upgrade compared to the previous non basic reactions, which required high
temperature (150 - 200 "c)?~The base was believed to generate a more nucleophilic
alkoxide ion, which resulted in faster attack to the metal, thus enhancing the reaction
rates3'
Transition metalcatalyzed transfer hydrogenation may result in the formation of
chiral products if conducted in the presence of chiral ligands. The ligands feature various
combinations of phosphorous, nitrogen, oxygen, or sulfur.20aMany prochiral ketones,
imines and activated olefins, which are limited to conjugated acid and amino acid
derivatives, may be hydrogenated via asymmetric transfer hydrogenation. The
enantiomeric excess (ee) of the product depends on the substrate type, the catalyst and the
reaction conditions.
For example, the carbonyl group in acetophenone can be reduced with 1 mole %
of (lR,2S)-(+)cis-l-amino-2-indanol,L1, 0.25 mole % of the ruthenium complex
28
29
30
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Chowdhury, R. L.; Backvall, I. E. Chem. Commun. 1991, 1063.
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[R~Cl&-cymene)]~
A and 2.5 mole % of KOH in isopropanol at room temperature to
give 70% yield and 91% ee (Table 1.1, entry 1 and Scheme 1.14).~'At lower temperature
(0 "C),the same reaction gave 49% yield with a slight increase in the enantiomeric excess

to 93% (Table 1.1, Entry 2). When the ligand was substituted with the less rigid (R)phenylglycinol, L2, the enantiomeric excess dropped to 23% but the yield increased to
95% at room temperature (Table 1.1, entry 3). The use of another ruthenium arene
complex [RuCl2(mesitylene)]2 B gave 73% yield and 82% ee (Table 1.1, entry 4). When
the catalyst was replaced with ruthenium arene complex B and (S,S)-TsDPEN, L3, the
yield and the enantiomeric excess increased to 95% yield and 97% ee (Table 1.1, entry
5).31This last result is comparable to what obtained from gaseous hydrogenation (Scheme
1.9, eq. 1). The rate and enantioselectivity of asymmetric transfer hydrogenation may also
be affected by the bulkiness and electronic properties of the subst~ate.~'

Scheme 1.13: Transfer Hydrogenation with RuCI2(PPh3)3.
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Scheme 1.14: Transfer Hydrogenation with RuCl(arene)/Chiral Ligand Complexes.
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Figure 1.8: Conventional Mechanism of Transition-Metal-CatalyzedTransfer
Hydrogenation with Isopropanol.

M-H

The mechanism of the metal-hydride mediated transfer hydrogenation may
involve direct coordination of the substrate to the metal center (the inner sphere
mechanism) or hydrogen bonding and dipolar interactions of the substrate with two
different sites of the catalyst (metal-ligand bifunctional catalysis, outer sphere
mechanism) depending on the structure of the ligand.20a.27.

33

In the inner sphere

mechanism, the metal may form a monohydride (MH) or dihydride (MHz) species
depending on the metal. It has been proven via deuterium experiments that rhodium- and
iridium-catalyzed reactions follow the monohydride pathway34where ruthenium follows
the dihydride pathway.27
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Figure 1.9: Non-Classical Metal-Ligand Bifunctional Mechanism of Transfer
Hydrogenation with Isopropanol.

7 '?

Base

R

-HX

M':y-H

7

:N-M
16e

Regardless of the metal species, the conventional (inner sphere) mechanism of
transition-metal-catalyzed transfer hydrogenation involves & i t coordination of the

.
1.8 outlines the mechanism of transfer hydrogenation with
substrate to the metal.33 Flgure
isopropanol and transition metal, in which X represents a halide. Base is required to

generate the isopropoxide ion, which coordinates to the metal and then undergoes

P-

elimination to generate the metal hydride (15) and acetone. Coordination of the substrate,
which, in this example, occurs through the carbonyl group, to the metal center followed
by a hydride transfer gave intermediate (17). Hydrogenolysis of (17) gives the reduced
product (18) and the catalyst goes back to the start of the cycle.33
The non-classical (metal-ligand bifunctional catalysis, outer sphere) mechanism
occurs with diamine catalysts such as Ru-(S)-XylBINAP-DAIPEN (Figure 1.9), which
Noyori terms a metal ligand bifunctional catalyst.27Theoretical calculations along with
experimental findings suggest that the hydrogenation of the carbonyl group takes place
via the six-membered ring transition state shown in Figure 1.9(a).'~ The 18-electron metal
hydride complex is regenerated by dehydrogenation of isopropanol with the 16-electron
metal amide via the same six-membered ring. The reaction involves the participation of
both the metal and the ligand. Neither the substrate (carbonyl) nor the hydrogen donor
(isopropanol) interacts directly with the metal center. The reduction occurs in the outer
sphere of the metal hydride complex.'3

1.3.3 Summary of Asymmetric Transfer Hydrogenaton
Transfer hydrogenation occurs via two major pathways, the Meerwein-PonndorfVerley (MPV) pathway, where a metal hydride is never formed and the hydridic pathway,
which occurs via the formation of a metal hydride. Within the hydridic pathway, there are
two mechanisms: the conventional metal hydride mechanism (inner sphere), which
involves direct coordination of the substrate with the metal and the metal-ligand
bifunctional mechanism (outer sphere), where the substrate doesn't directly coordinate to
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. in asymmetric hydrogenation, asymmetric transfer hydrogenation
the metal center.27 Llke
(ATH) transforms prochiral substrates to their reduced products in high yield and
enantiomeric excess with the help of c h i d ligands.
There are many advantages associated with the asymmetric transfer hydrogenation
reaction. It is a cheaper, safer and the yield and enantiomeric excess are comparable to
that obtained from gaseous hydrogenation. Extensive effort is given to this area in organic
synthesis due to the low cost and favorable properties of the hydrogen donor as well as
the operational simplicity.20b

1.4 Conclusion

Asymmetric catalysis is a powerful tool in organic synthesis.33 Since its modest
beginning in the 1960s, this field in organic chemistry has revolutionized the way
synthetic organic chemists operate. Continuous effort is given to this area and many
catalysts have been developed to improve the reactivity and enantioselectivity of the
reaction to practical levels.
Lately, new catalysts are being used in transfer hydrogenation, which often result
in similar yield and enantioselectivity without the danger associated with the high
pressure in gaseous hydrogenation. Several catalysts have been reported to be efficient in
the asymmetric transfer hydrogenation of carbonyls, imines, and activated olefins like
conjugated carboxylic acid and amino acid derivatives. However, there has not been any
example of asymmetric transfer hydrogenation of an allylic compound. In this thesis, the
synthetic and mechanistic aspects asymmetric transfer hydrogenation of allylic alcohols
with ruthenium catalysts will be presented.

CHAPTER 2: CHIRAL METHOD DEVELOPMENT
2.1 Introduction
At the early stage of this project, the enantiomeric purity was determined by
derivatizing the reduced product (citronellol) with (S)-Mosher acid chloride, [S-(+)-

methoxy-trifluoromethylphenylacetyl chloride], followed by chromatographic separation
of the diastereomers. The diatereomers, S-Mosher-S-citronellol and S-Mosher-Rcitronellol, were separated using a Daicel Chiralcel OJ HPLC column. This method was
used at the beginning of the project but was considered expensive and unreliable due to
the discrepancy obtained when coupled the racemic citronellol with the S-Mosher acid
chloride; a 5 - 6 % diastereomeric excess (de) was obtained. Searching for a cheaper and
more reliable chiral separation method became our first priority.

2.1.1 Background

Chirality is now a major theme in the discovery, development, and
commercialization of new drugs. About half of drugs in use are c h i d and about 25% of
them are administered as pure enantiomers due to their chemical and pharmacological
behavior.35 It is well know that in most cases the pharmacological activity is restricted to
one of the enantiomers (eutomer) whereas the other enantiomer (distomer) has either no

~ example, in the late 1960s thalidomide
activity or can even be toxic (Table 2 . 1 ) . ~For
(softenon@)was found to be a seriously teratogenic for causing birth defects in more than
10,000 babies as it was prescribed for morning sickness to pregnant women.37 It was later
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discovered that these anomalies were due to a single enantiomer of this chiral molecule.
Consequently, the separation of enantiomers has become a major field in pharmaceutical
industries.

Table 2.1: Differences in Pharmacodynamic ~ c t i o n . ~ ~
Isomers Producing Different types of Toxicity
Chemical
Effect of (+)-isomer Effect of (-)-isomer
Thalidomide
Teratogenic
Nonteratogenic?
Peripheral effect least
Hyoscyamine
Most potent (ten-fold)
potent
l~somersProducing Different types of Therapeutic Effect
~ydrox~-~-methyl
Analgesic
Antitussive
morphinan
Local anaesthetic &
Local anesthetic
Bupivacaine
vasoconstrictor

I

One Isomer Responsible for The Therapeutic Action, The Other Toxic
Therapeutic effect Toxic effect

Timolol

Dialkylphosphates

Reduction of
intraocular pressure
(RS-forms)
Pepticides in insects
(no therapeutic
benefict)

P-Andrenergic antagonism
(S-form)
Inhibition of neurotoxic
esterase leading to
neurophaty ((-)form)

It is worth noting that racernic thalidomide

halomi mid^) in combination with

dexamethasone is now one of the best treatments in the market for multiple myeloma
(bone marrow cancer). It is also used to treat and prevent the debilitating and disfiguring
skin sores caused by erythema nodosum leprosum (ENL), an inflammatory complication

of leprosy.38 Thalidomide is being sold as a chiral mixture because it racemizes in the
body. Therefore, it passes the Food and Drug Administration (FDA) guidelines for the
development and commercialization of chiral drugs.39 It is preferred that new drugs only
contain the active enantiomer when it is demonstrated that it is not converted to the
distomer in vivo or during storage. For the registration procedure, the FDA requires a
chiral method capable to qualify the distomer from the eutomer. As a result, more
industries are dedicated to the separation of stereoisomers.

2.1.2 Major Types of C h i d Techniques

There are many techniques for the analysis and separation of chiral molecules.
Some non-chromatographic techniques include polarimetry and nuclear magnetic
resonance (NMR) spectroscopy. The disadvantages of these techniques are the need of an
enantiomerically pure reference sample and the enantiomers are not separated during the
analysis. The most popular types of c h i d techniques are gas chromatography (GC) and
high performance liquid chromatography (HPLC).These techniques are preferred because
pure enantiomers are not required and the separation of the enantiomers does take place.40
Furthermore, these chromatographic techniques can be used to prepare enantiomerically
pure molecules.
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2.1.3 Cltiral HPLC as a Separation Technique
Chiral HPLC is one of the best and most widely used chiral separation techniques.
The separation can be direct, which involves the use of a chiral stationary phase (CSP) or
c h i d mobile phase (CMP), or indirect, which involves derivatization of the enantiomers
prior to the analysis.40The separation of enantiomers over the CSP is well understood.
The enantiomer that forms the strohger association with the CSP will be the more
strongly retained, thus, it will have a longer retention time ( t ~ )The
. enantioselectivity (a)
of the c h i d chromatography system is then expressed as the ratio of the retention factors
of the two enantiomers (Eq. 2.1). 41,

42

Eq. 2.1
a = (~R(R)
- W(~R(S)
- to)
where to = void time and t~ = retention time of the enantiomers R and S.

This ratio may sometimes be close to the value of the thermodynamic
enantioselectivity of the association of the CSP with the enantiomers. On the other hand,
the more polar mobile phase reduces the t~ of the enantiomer that forms the stronger
association with the CSP. Therefore, the effective enantioselectivity of the
chromatographic system will be proportional to the ratio of the enantioselectivity of the
association processes in the stationary and mobile phases (Eq. 2.2).41,42
There are many other factors that can affect the retention, resolution, and
stereoselectivity of chiral compounds. Some of these factors include temperature, flow-
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rate, mobile phase composition, and pH. For example, some enantiomers contain amino
or hydroxy groups that might hydrogen bonds with the stationary phase; the pH of the
mobile phase can increase the solvation of the enantiomers, thus, enhance the peak shape
and t ~42,. 43 A similar effect can be obtained by increasing the temperature of the column,
increasing the flow-rate, or increasing the polarity of the mobile phase. Although the pH
and temperature have a great effect on the peak shape, they have a small effect on the t ~ .
The flow-rate and the mobile phase composition have greater effects on the t ~ Steric
.
repulsion and the pH, ion strength and temperature of the mobile phase all affect the
resolution of enantiomers.
Despite the great understanding of the chiral HPLC system, a successful chiral
separation is often not predictable based on the CSP structures. Finding the right CSP for
the separation of enantiomers can be very difficult. In most cases, the chiral separation is
obtained by trying various CSPs. One can understand the interactions among the
enantiomers, the CSP, and the mobile phase, but still has difficulty of obtaining a
successful enantioseparation. The decision of choosing the right CSP relies mostly on
empirical data or by using predictive empirical rules that have been developed based on
empirical structures.

2.1.4 Chiral GC as a Separation Technique
Chiral GC is another efficient and reliable technique for the separation and
quantitation of enantiomers and dia~tereomers.~~
It is mainly used for volatile and
thermally stable solutes. In general, the retention time (tR)of the solute is determined by
43
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the solute's boiling point; except where there are specific interactions with the stationary
phase, which is the basis of chiral separation. Just as in the chiral HPLC, enantiomers can
be separated by either direct or indirect methods in the GC. The indirect methods involve
derivatization of the enantiomers to diastereomers using a homochiml reagent, followed
by separation on an achiral GC column. The direct separation is the most desired method;
the success relies on direct separation of the enantiomers using a c h i d stationary phase
(CSP). In this method, the enantiomers form rapid and reversible transient diastereomers
with the CSP. It is a straightforward method and avoids all problems associated with the
chiral derivatization process in the indirect method. Except for very polar compounds,
such as alcohols, amines, and acids, no pre-column derivatization is required to separate
enantiomers.
Based on the interaction with the enantiomers, the CSPs are divided in three
major categories: 1) diamine and amino acid derivatives which form hydrogen bonds with
the analytes; 2) chiral metal complexes which coordinate to the analytes; and 3)
cyclodextrin (CD) derivatives which separate enantiomers by dipole-dipole interations, or
by forming an inclusion complex with the analytes. Among the three types of chiral
selectors, the CD derivatives remain the most popular CSPs in enantioselective GC
(Figure 2 . 1 ) . ~ ~
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Figure 2.1: Application of Different GC Chiral Stationary Phases from 1/01 to 7/04.
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Figure 2.1 summarizes a survey on publications discussing separation of
enantiomers with various c h i d capillary GC.44From January 2001 to July 2004, the use
of chiral metal stationary phases has dramatically diminished; the amino acid derivatives
CSPs are limited to specific applications; but the CD derivatives account for nearly 90%
of successful enantiomeric GC separations.
Chiral stationary phases based on CD derivatives remain popular in recent years
due to their versatility. Their applications cover almost all the fields where other CSPs are
applied.45There are many types and sizes of CSPs based on CD derivatives. Depending
on the cavity size and percentage of cyclodextrins (a, P, or y), different enantiomeric
selectivities are obtained. It is also believed that the type, the site, the percentage, and the
degree of substitution on positions (2-, 3-, and 6-position of glucose unit of CD) of the
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substituents all influence the enantioselectivity of the CSP. Therefore, the synthesis of the
CD derivatives must be carefully controlled and final structures must be fully
characterized to avoid reproducibility

A list of CD derivatives and their

recent applications are summarized in Table 2.2."

Table 2.2: Derivatized Cyclodextrins and their Recent Applications in Chiral GC."

r

1

1
I GC chiral selector 1
Hexakis (2.6-diOpentyl-3-0trifluoroacety1)-acyclodextrin
Hexakis (2,3,6-tri0-penty1)-
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Coated
or
bonded
Coated

Zhiraldex A-

Coated

ipodex A

n = 6: alphacyclodextrin
n = 7: beta-cyclodextrin
n = 8: gamma-cyclodextrin

Application

,
1 ASTEC

I-MachereyNagel

x-Ketoester
iydrogenation

a) Schurig, V. J. Chromntogr. A 2001,906 (1-21,275;b) lunge, M.; Konig, W. A. J. Sepn. Sci. 2003.26,
1606;c ) Jaus,A.; Oehme, M. J. Chromtogr.A 2001 905,59; d) Chena, G.;Shi, X . Anal. Chim.Acta
2003,498, 39.

3eptakis (2,3-di-

Coated

1 p-DEX325 1 SUPELCO 1 Lactone thio, thiono, 1
STEC
&W
kientific
vlachereyJagel
lestek
3GB
balpik

Heptakis (2,3-diCoated
O-ethyl-69-teabutyldimethylsilyl)
3-cyclodextrin
Coated
Heptakis (2,3-diO-acetyl5-0-teabutyldimethylsilyl)

Restek
MeGA

SUPELCO
Restek

Iithioderivatives
3icyclic y-lactone
1-Butyrolactone
ierivatives
I-Irones
'CBs
Merpene
3icycloheptane
1-HCHs
?ITS
fletolachlor
'01 ychlorinated
Bipyrrole
Sesquiterpenes
Essential oils
bfonoterpenes
Sulfoxides and sulfinat
:sters
1,2-0-isopropylidenesn-glycerol
Flovour
Secondary alcohols
Sex pheromone
Positional isomers
Pesticides
Fragrances
Methyl
dihydrojasmonates
Monoterpene,
Chiral alcohols
3-Hydroxy acids
Positional isomers
Essential oils
Lactone thio, thiono,
dithioderivatives
8, y-lactones
Sex pheromones
3-Hydroxy acids
Aroma

Heptakis (2,6-di-

soprenoids
ting-bonded a-amino
icids
Jhiral acids
h i n o acid derivatives
Sex pheromone
rerpenes
Mandelates and its

Coated

:oated

malogs
Ioated

:hira ldex B'A

ASTEC

k n i t i n e derivative

:oated

XDEX-B
:p:yclodextrin

SGE Ltd, UK
VarianKhro
mPack
SUPELCO
J&W
Scientific
MachereyNagel
Restek

PCBs
Glucopyranosides
Polychlorinated
substances
Quinolizidine
Furan derivatives
Odorants
Ketones
a-Ketoester
hydrogenation
Tartaric acid
Sex pheromones
Hydroxy acids
Amino acid derivatives
Curtisians
Essential oil
Positional isomers
Monoterpenes (aroma)
Fragrance
a-Hydroxy fatty acids
PCBs
CTTs
Diterpenes
Terpenes
Aliphatic hydrocarbons
Aryl- and
heteroaqlcarbinols
Sex pheromones

I-

!,3,6-M-19
I-DEX 120
lyclodex-B
Iydrodex-P'M
tt-PDEXm

Bonded

Jhirasil-DEX VarianIChro
mPack
JB
Restek
Jhirasil-P]ex

r 7

Heptakis (2,3,6-tri- IBonded
0-methyl)P-cyclodextrin
Heptakis (2,3,6-tri- Zoated
O-tertbutyldimethylsilyl)

Racemic-conglomerate
Crystallization
PCBs
Pesticides

Chirasil-pDex
BGB-172

P-cyclodextrin
Heptakis (2,3,6-tri0-ethyl)P-cyclodextrin

Methyl-branched
alcohol
and acids sulfurcontaining
aroma
Thiazolinecarboxylates
PCBs

Eoated

Coated
.

Chiraldex BPH

cyclodextrin
Coated
Octakis (bistertbutyldimethylsi
1~1)y-cyclodextrin
Octakis (2,3-di-0- Coated
acetyl-6O-tertbutyldimethylsilyl)

Metalaxyl

SUPELCO
Zestek

Branched hydrocarbons

-

y-cyclodextrin
--

Sesquiterpene

Octakis (2.6-di-0methyl-30-penty1)-ycyclodextrin
Octakis (2,6-di-pentyl-30-trifluomacety1)y-cyclodextrin

Coated

Coated

Chiraldex GTA

ASTEC

Octakis (2,6-di-0pentyl-30-propiony1)-ycyclodextrin
Octakis (2,3,6-tri0-methyl)y-cyclodextrin

Coated

Chiraldex GPN

ASTEC

Coated

SUPELCO
SGE Ltd, UK

Glucopyranosides
(aroma)
Sulfoxides and sulfinate
esters
Epoxides
~"bstitutedcarbocyclcs
Sulfoxides and sulfinate
esters

Bicyclic y-lactone
Alkaloids,
herniterpenoids
Chlodane

Octakis (2,3,6-tri-

Coated

Pesticides

I

-y-cyclodextrin
Octakis (3-0-

?oated

Lipodex-E
MachereyChiraldex G- Nagel
BP
ASTEC

Cyclic P-ketoesters
Amino acids
Flavor compounds
Sulfoxides and sulfinate
esters
Lactones
Insecticides
Essential oils
Anesthetics
Halodiether B

Bonded

Chirasil-yDEX

Halogenomethanes

butanoyi2,6di-0-penty1)-ycyclodextrin

Octakis (2,3-di-0pentyl6-0-methyl)-ycyclodextrin

Isoprenoids
Homoterpene esters
Chiral alcohols
Sex Pheromones

As shown in Table 2.2 the CD derivatives CSPs are applied in the separation of a
broad range of chiral molecules including essential oils, flavours and fragrances,
alcoholic beverages, clinical chemistry, terpenoids, and pesticides. For example, volatile
chiral sulfoxides, which are important bioactive compounds, are easily separated with

heptakis(2,2-di-O-pentyl-3-trifluoroacetyl)--cyclodexrin
(DPTFA - GCD).~' Mandelate
analogs, which are important intermediates in pharmaceutical chemistry, are separated on
both heptakis(2,3,6-tri-0-methyl)-P-cyclodextrin(PMBCD) and heptakis(2,6-di-0-nonyl-

3-0-trifluoroacetyl-P-cyclodextrin (DNTBCD).48 Both coated and bonded PMBCD
phases are suitable for the separation of saturated chiral aliphatic hydrocarbons,
geometrical isomers of furan derivatives, positional isomers of xylenes and

dimethylnaphthalenes, aryl- and heteroarylcarbinol, and a-hydroxyl fatty acid esters.49
The octakis(3-O-butanoyl-2,6-di-n-pentyl)-y-cyclodextn
phase is extremely useful in the
separation of chiral halogenomethanes and various chlorinated and fluorinated ethers
(inhalation

anesthetic^).^^ Therefore, CD based CSPs are classified as the most powerful

tool in GC for separation on enantiomers.

2.1.5 NMR in Chiral Analysis
Nuclear Resonance Magnetic (NMR) spectroscopy is one of the most important
methods used to determined optical purity of different classes of compounds. Although it
is easily accessible, the NMR does not differentiate enantiomer~.~'
Derivatization with a
pure chiral auxiliary reagent to produce diastereomers must be performed prior to
analysis. The chemical shifts of the diastereotopic nuclei will be different, which under
the ideal condition results in baseline separation. Integration of the S and R diastereotopic
nuclei leads directly to the estimation of enantiomeric purity.
One type of chiral auxiliary agent used in NMR is the c h i d lanthanide shift
reagents. The lanthanide forms diastereomeric complexes in situ with the substrate
enantiomers and may be used directly.s2 There are many lunds of lanthanide shift

47

Aderson J. L.; Ding, J. McCulla, R. D.; Jenks, W. S.; Armstrong, D. W. J. Chromatogr. A 2002,946,
197.
48
Nie,M. Y.;Zhou,L. M.; Wang, Q . H.;Zhu,D. Q.Ana1. Sci 2001,17(10), 1183.
49
a) Meierhemich, U.J.; Nguyen, M. J.; Barbier, B.; Brack, A.; Thiemann, W. H. P. Chirality 2003.15,
S13. h) Kasai, H. F.; Tsubuki, M.; Takahashi, K.; Shiiao, M.; Matsumoto, Y.; Honda, T.; Seyama, Y. J.
Chromatogr. A 2002,977,125. c) Pivovar, A. M. K.; Holman, T.; Ward, M. D. Chem Muter. 2001,13,
3018. d) Uray, G.; Stampfer, W.; Fabian, W. M. F. J. Chromatogr. A 2003,992, 151. e) Tokamolthom 1.;
Chen, S. T.; Jeyasshoke, N.; Krisnangkura, K. Anal. Chirn. Acta 2002,465,299.
M
a) Crassous, J.; Jiang, Z.; Schurig, V.; Polavarapu, P. L. Tetrahedron:Asym. 2004,1S, 1995; h) cf. 46a;
C)Schurig, V.; Schmidt, R. J. Chromatogr. A 2003, IWO, 311.
51
Dufrasne, F.; Gelbcke, M.; Galanski, M. Spectrochimica Acta Pan A 2006,65,869.
52
Parker, D. Chem Rev. 1991,91,1441.

reagents, the most common ones are shown in Table 2.3. Addition of lanthanide shift
reagent to an organic compound results in the resolution and the chemical shift of the
enantiomeric signals move to lower frequencies. The lanthanide forms a weak addition
complex with a large variety of organic compounds (alkenes, arenes, allenes) that is in
fast exchange with the unbound organic substrate. This fast exchange results in line
broadening of the signals, which makes it often preferable to acquire spectra on a 100MHz instrument rather than a 500-MHz instrument where line broadening is 25 times
more severe.s2 The line broadening represents a major disadvantage in this method. Even
when special care is taken in the data acquisition (use of dry shift reagent, use of
Gaussian line narrowing methods and base-line correction routines), the % error may be
as high as 10% especially when the ee is >90%.
Nuclear magnetic resonance (NMR) spectroscopy is based on the net absorption
of energy in the radiofrequency region of the electromagnetic spectrum by the nuclei of
certain elements in a molecule. All nuclei are assigned a spin quantum number, I, on the
basis of the number of protons and neutrons in the nucleus. The number of permitted
orientations in space that can be adopted by a nucleus subjected to a magnetic field is
given by (21 + 1). For I = ?h,two orientations or energy levels are possible. Therefore,
nuclei with even numbers of both protons and neutrons, for example

I2c,160,
and 3 2 ~ ,

have a spin quantum number of zero, no spin angular momentum, cannot give an NMR
spectrum; where nuclei with a spin quantum number of ?h, including proton, carbon-13,
phosphorus-31 and fluorine-19, will give an NMR spectrum.43Any nucleus capable of
giving an NMR spectrum can be used to identify the structure and optical purity of

organic compounds. However, because 'H and

I3care

the most widely studied spectra,

they remain the most p o & u tools for the determination of chiral purity.

Table 2.3: Common Chiral Lanthanide Shift ~ e a ~ e n t s . 5 '
Structure of L in LnL3

I

Lanthanon

Abreviationa

Europium (Eu)

EuFtfc13

Praseodymium (Pr)

Pr[tfcI3

Ytterbium (Yb)

Yb[tfc13

Europium (Eu)

Eu[hfc]3

Praseodymium (Pr)

Pr[hfcI3

I

0R = CF,

0R = C3F7

I
I

Ytterbium (Yb)

I
I

'pvc = pivaloy-dcamphorato; tfc = trifluorohydroxymethylene-d-camphorato;
hfc = heptafluorohydroxymethylene-d-camphorate; dcm = dicamphoyl-d-methanato.

Nuclei of a particular element that are in different environments generally
experience slightly different applied magnetic field strengths due to the shielding and
deshielding effects of nearby electrons. Consequently, their resonance frequencies vary
and each frequency is defined by a characteristic chemical shift value. On the other band,

the chemical shift of a particular element, whether chiral or achiral, remains unchanged in
similar environment. After derivatization. the introduction of a second chiral center
changes the environment of the first chiral center along with some neighboring
(diastereotopic) elements in the same molecule. As a result, two different chemical shifts
may be obtained for the diastereotopic nuclei. For example, Figure 2.2 and Figure 2.3
show the proton and carbon NMR spectra of N-(((1R,5S)-6,6-dimethylbicyclo[3.l.l]hept-

2-en-2-y1)methylene)-1-phenylethanarnine,22, (Scheme 2.1)."
Scheme 2.1: Reaction of 1-phenylethylamine(21) with the C h i d Derivatizing Agent
(CDA) (-)-mytend (20).

(CDA) (-)-myrtena
20

1-pheny ethy am ne
21

Three samples of 1-phenylethylamine21 were prepared in three different ratio of
R:S enantiomers as follows: (a) 50:50, (b) 33.4:66.6, and (c) 14.435.6. After
derivatization

with

(1R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-ene-2carbaldehyde,

commonly known as (CDA) (-)-myrtenal 20, the resulting diastereomers were analyzed
by proton and carbon NMR. In the proton NMR (Figure 2.2), the spectral region of the
imine proton (7.88 ppm) is shown and the diastereomeric ratios are found very close to
the enantiomeric values: (a) 50.5:49.5, (b) 34.3:65.7, and (c) 15.7534.3. In the carbon
NMR (Figure 2.3), the spectral region of C3=N-C (159.C~161.7ppm) and C=N-CI
(67.8-70.5 ppm) are shown. The ratios are also found to be consistent with the expected
values: (a) 50.3:49.7 for C3 and 49.5:50.5 for C1; (b) 34.5:65.5 for C3 and 34.3:65.7 for
57

C1; and (c) 15.1:84.9 for C3 and 15.8:84.2 for C1. Better baseline resolution occurs in
the "C experiments.

Figure 2.2: Proton NMR of N-(((1R,5S)-6,6-dimethylbicyclo[3.l.l]hept-2-en-2y1)methylene)-1-phenylethanamine (22).5L

Figure 2.3: Carbon NMR of N-(((lR,5S)-6,6-dimethylbicyclo[3.l.l]hept-2-en-2y1)methylene)-1-phenylethanarnine (22)."

Nuclear magnetic resonance (NMR) spectrometry also has its disadvantages.
Resolution of the diastereotopic protons is not always obtained. In the above example
58

with 1-phenylethyamine, complete baseline separation was not achieved in the proton
NMR (Figure 2.2); integration and determination of the R:S ratio was possible by using
automated deconvolution and integration. Other examples in the same study resulted in
complete overlap of the diastereotopic protons; I3cNMR was used in those cases, yet the
difference in the expected ratios was as high as 6% in some cases. These errors are not
only due poor resolution of the diastereotopic peaks; impurities in the chiral resolving
agent combined with different reactivity of the enantiomers contribute to the discrepancy.

2.2 Results and Discussions
2.2.1 Derivatim'on with Mosher Acid Chloride and Diastereomeric Excess
Determination by HPLC
2.2.1.1 Introduction
Mosher acid (a-methoxytrifluorophenylacetic acid) was first used by Harry S.
Mosher as a chiral derivatizing agent in the late 1 9 6 0 s . ~The
~ chiral reagent reacts with
alcohols or amines of unknown stereochemistries to form esters and amides. The absolute
configuration of the ester or amide is then determined by proton NMR spectroscopy?4 To
increase the reactivity of the Mosher acid, it is often converted to the acid chloride prior
to the coupling

reaction^?^

One of the most popular methods used to determine the enantiomeric purity of
citronellol is by derivatizing it with the (R) or (S)-Mosher acid chloride. In our case, the
(R)-Mosher acid chloride was used (Scheme 2.2). The R-citronellyl-R-Mosher ester and
53

Dale. J. A.; Dull, D. L.; Mosher, H. S . J. Org. Chem.1969,34 ($9,2543

the S-citronellyl-R-Mosher ester are diastereomers, thus could be separated with an
achiral column. However, attempts to separate these diastereomers using C18 columns
were unsuccessful. We found that they could be separated using a chiral HPLC column.

Scheme 2.2: Derivatization of Citronellol with R-Mosher Acid Chloride.
R-mosher acid

Citronellol
23

Et3N, 3 eq.
DMAP, 0.1 eq.

25

CH&

2.2.1.2 Results and Discussion
Figure 2.4 shows the chromatogram of the citronellyl-Mosher esters. This
particular example is from the reaction of a mixture of 41:59 R:S citronellol. After
derivatization with R-Mosher acid chloride (3 equiv), a ratio of 43.1:56.9 of RR:RS
diastereomers was obtained at 210 nm and 42.5:57.5 of RR:RS was obtained at 220 nm
with a range of 3.7 to 4.8% difference from the expected ratio. This percent difference
was even larger (6%)56 when 1.5 equiv of Mosher acid chloride was used in the
derivatization reaction.

''
''

Allen, D. A.; Tomaso, A. E. Jr.; Priest, 0.P.; Hindson, D. F.; Hurlburt, 1. L. J. Chern. Educ. 2008.85,
698.
Ward, D.E.; Rhee, C. K. Tetrahedron Lett. 1991,32 (49),7165.
56
Laquidara, J. M.Ph. D. Dissertation, Department of Chemistry and Biochemistry, Seton Hall University,
South Orange, NJ,2003.

Figure 2.4: HPLC Chromatogram of Citronellyl-Mosher Esters.
Chromatographic Conditions: Diacel Chiralpack OJ-H, 250 mm x 4.6 mm; 90: 10
to 50:50, ethanol:hexanes, 0.6 W n , 20 minute gradient; room temperature;
210 and 220 nm.

Although satisfactory baseline separation was obtained from the Diacel Chiracel
OJ-H HPLC column, finding a better chiral method was still needed. The 5% to 6%
difference was too high for our purpose since we were expected citronellol as high as
98% ee from the transfer hydrogenation reaction. In addition, to reduce the discrepancy in
the reactivity of the R and S enantiomeris of citronellol, a large excess (about ten equiv)
of the pure (>99% ee) Mosher acid chloride would have to be used. That would require
about 556 mg of the Mosher acid chloride for each reaction of 35 mg of citronellol. The
cost of the Mosher acid chloride from Aldrich is $2921500 mg. Therefore each
derivatization would cost over $324 for a more accurate result; or a minimum of $49 if
only 1.5 equiv of the Mosher acid chloride is used, which gives a 6% difference.

toluene, resulted in the decomposition of the starting material; the product was never
obtained. Our initial work with oxalyl choride in refluxed methylene chloride were also
unsuccessful. Maybe higher temperatures were damaging to the reaction. So we decided
to conduct the reaction at room temperature following Nagasawa's procedure with neat
oxalyl chloride.58aThe problem with this procedure is that the product was obtained as a
sluny; filtration of the sluny gave a yellow solid in very low yield. Using Wang's
isolation procedure (see Section 2.2.2.3

(S)-Naproxen acid chloride was

obtained as a white needle-shaped crystals in 88% yield. Subsequent treatment with
citronellol gave the diastereometic esters, which were analyzed by NMR.

Scheme 2.3: Derivatization of Citronellol with S-Naproxen.

--

-

c+
0

H3C0

neat rt

27

-

m

H3C0

Step 2

2.2.2.2 Results and Discussion

Four different samples of citronellol were prepared in the following ratios of R:S
enantiomers: (a) Aldrich racemic citronellol assumed to be 50:50, (b) 36.28:63.72, (c)

14236 and (d) 6:94. All four samples were converted to the (S)-Naproxen ester and the
resulting diastereomers were analyzed by

I3cNMR

(Table 2.4). The proton NMR was

not utilized because the (S)-Naproxen citronellyl ester diatereomers completely overlap
giving one set of signals. The carbon NMR mostly overlaps; but, four carbons gave
partial to complete separation with the best separation occurring for C3 of the citronellyl
chain, at 29.66 (R) to 29.7 (S) ppm (Figure 2.5).

Table 2.4: Comparison of Standard Citronellol Samples (a, b, c and d) with the (S)Naproxen Esters Results from I3cNMR.

Integration of the two diastereomeric peaks of C3 in 29 is summarized in Table
2.4 and Figure 2.6. The

I3cNMR

integration of C3 of the (S)-Naproxen citronellyl ester

gave the following R:S ratios: (a) 49.5850.42, (b) 32.22:67.78, (c) 6.14:93.86, and (d)
was difficult to integrate. The NMR result for sample (a) was in agreement with the
standard racemic citronellol, but the % difference for sample (b) was 4.06% and 7.86%
for sample (c). It was difficult to integrate sample (d) because there wasn't any baseline
separation; the (R) signal was too small. These results indicate that the derivatization
method with (S)-Naproxen followed by

13cNMR

analysis is useful to determine up to

36:64 R:S citronellol ratio. Any larger ratio would result in a % difference greater than

Figure 2.5: I3cNMR Segment of Sample (b) [(S)-Naproxen Citronellyl Ester].
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Figure 2.6: Comparison of Standard Citronellol Samples (a, b, c and d) with their (S)Naproxen Esters Results from I3cNMR.

rn % (R)-Citronellol prepared

This behavior was previously investigated in our group in the reaction of SNaproxen acid with ~ e c - ~ h e n ~ l e t h a nIto was
l . ~ ~found that S-sec-phenylethanol reacts 4.5
times faster than R-sec-phenylethanol with S-Naproxen. Therefore, incomplete reaction
during derivatization leads to residual unreacted alcohol (R-sec-phenylethanol), which
results in further discrepancy of the diastereomeric purity. It was then concluded that the
optimum amount of the resolving agent needed was ten equivalents.

2.2.2.3 Conclusions
Although S-Naproxen is about 100 times cheaper than the Mosher acid chloride, it
didn't meet our needs. Our NMR results show large discrepancies between the standard
citronellol enantiomers and the S-Naproxen diastereomers. The higher the enantiomeric
excess, the greater the dicrepancy. In addition, it was difficult to obtain a signal for the
minor diastereomer when the ee was >95%. In the future, however, it may be possible to
obtain better results if we follow improvements suggested by Li ~i~~ and use more
concentrated samples and long acquisition times to increase the

I3cNMR

sensitivity.

However, this method was rejected and the desire to find a better and cheaper c h i d
separation method was still present. We wanted to find a method capable of determining
enantiomeric excess greater than 95% ee with less than 5% difference.
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2.2.3 Direct Separation on Chiral GC Column
2.2.3.1 Introduction
Direct chromatographic separation of enantiomers is the most desirable method by
most analytical chemists.44 In most cases the method is faster and more reliable than
performing a derivatization. As mentioned above, derivation of citronellol with Mosher
acid chloride and Naproxen results in various levels of error and were not reliable at high
enantiomeric excess. Therefore, it was decided to determine the ee of the crude citronellol
using a c h i d GC column without derivatization.

2.2.3.2 Results and Discussion
To validate the chiral GC method, five standards of citronellol were analyzed.
Three samples were prepared and the racemic and enantiomerically pure S-citronellol
from Aldrich were also analyzed which gave a total of five standards in the following
ratios of R:S enantiomers: (A) racemic citronellol assumed to be 50:50, (B) 5.46:94.54,
(C) 3.48:96.52, (D) 2.43:97.57, and (E) S-citronellol (sold as >98% ee) 1:99 (Table 2.5).

All samples were prepared in three different concentrations in methanol
(0.01 M, 0.02 M and 0.1 M) and the % ee reported is the average of three data points.
These concentrations were selected based on our reaction concentration (0.01 to 0.1 M),
but, excellent baseline separation can be obtained for racemic citronellol at 1 M
concentration (Figure 2.8). The chiral GC results for the standard citronellol samples (A,
B, C, D and E) are summarized in Table 2.5 and a schematic representation of these
results is shown in Figure 2.7.

Orange, NJ, 2005.

Table 2.5: Cornparaison of Standard Citronellol samples (A, B, C, D and E) with the
Chiral GC Results.

Figure 2.7: Comparison of Standard Citronellol Samples (A, B, C, D and E) with the
Chiral GC Results.

The ee found for the racemic citronellol is very close to the expected value, giving
a difference of less than 0.1%. The S-citronellol from Aldrich has an optical purity of

298%. Our chiral GC method revealed 97.91% (S), with a difference of -0.09%. Sample
B was found to have a difference of 0.08% and sample C 0.1%. The largest % difference
was obtained from sample D, which was 0.45%. In summary, the ee found for all the
purchased and prepared standards using our chiral GC method were very close to the
expected values. In addition, the cost of a RT-BetaDEXsa column is less than $700.
However, it is recommended to use proper care to extend the life of this column. For a
short-term standby mode, it is suggested to leave the column in the GC with the carrier
gas flow on at an oven temperature of 100 - 150 "C. For long-term storage, it is
recommended to remove the column from the GC and store away from strong light6'
Figure 2.8: Chiral GC of 1 M Citronellol in Methanol.
Chromatographic conditions: RT-BetaDEXsa column, 30 m x 0.32 rnm ID x 0.25 mrn;
inlet, split mode (50:1), 150 "C; column, isothermal 80 "C, He flow 30 mumin, 15 psi,
120 min; detector 150 "C; 10 p1 injection.

2.3 Conclusions
Three chiral methods were tested in the separation of R and S enantiomers of
citronellol. Our validation studies reveal that direct separation using a chiral GC column
was the most reliable method. The RT-BetaDEXsa GC column gives baseline separation
for citronellol of 298% ee with less than 0.5%error. This method is faster, cheaper and
more reliable than doing derivatization with either Mosher acid chloride or S-Naproxen.
Derivatization with the Mosher acid chloride gave a moderate HPLC baseline
separation for the diastereomers with a 5 - 6 % difference when using racemic citronellol.
We did not investigate how this percent error would change at higher R:S or S:R ratios of
citronellol. However, this method was abandoned due to the high cost of the Mosher acid
chloride, $29'21500 mg.
S-Naproxen is a cheaper derivatizing agent; it is nearly 100 times cheaper than the
Mosher acid chloride. The

13cNMR of the diastereomers of the racemic citronellol gave

good baseline separation with a 0.42%difference. However, this error got larger at higher
R:S citronellol ratios. A 7.86% difference was obtained from a 14:86 R:S citronellol
mixture and this method failed to give any result for a 6:94 R:S citronellol mixture.
As shown above, the chiral GC method gave excellent baseline separation for
citronellol of 298% ee with a difference of 0.09%.The largest difference obtained with
this method was 0.4596, which may be related to some measurement errors. The errors
associated with umeacted citronellol or with different rates of reaction of the chiral
auxiliary during derivatization were no longer a problem. This method is direct, fast and

reliable. So it was decided to determine the enantiomeric excess of our reaction mixtures
by c h i d GC.

CHAPTER 3: ASYMMETRIC TRANSFER HYDROGENATION OF ALLYLIC
ALCOHOLS
3.1 Introduction
Assymetric transfer hydrogenation (ATH) is an alternate process of performing
asymmetric hydrogenation of prochiral substrates in high yield and enantioselectivity
without the danger associated with hydrogen gas. Most ATH reactions are conducted in
the presence of IPA or formic acidhiethyl arnine mixtures as hydrogen donors, which
eliminates the need for a pressure vessel. ATH is a safer, cheaper and an operationally
simpler process. There have been many examples of transfer hydrogenation reactions in
the literature. The reduction of ketones, aldehydes and imines are among the most
common exampleszoas25'

28' 31. 32, 61 and

the reduction of a$-unsaturated acids are less

'@
6z Furthermore, there have been examples of transfer hydrogenation of

common.

allylic alcohols.63 However, those examples resulted in no enantioselectivity.
Ruthenium catalyzed asymmetric transfer hydrogenation (ATH) of allylic alcohols
is a novel reaction. The reaction was discovered in our research group by Joseph
Laquidara while he was doing his Ph.D. with Prof. John R. Sowa. While attempting to
catalyst,
isornerize geraniol to y-geraniol with the [RUC~~((S)-(-)-~O~BINAP)]~/N(C~H~)~
instead of obtaining y-geraniol, citronellol was obtained in 27%yield and 50% ee. To our
knowledge, this is the first example of asymmetric transfer reduction of an allylic alcohol.

61

62

a) Ahn, K. H.; Ham C.; Kim,S. K.; Cho, C. J. Org. Chem. 1997.62.7047; b) Zassinovich, G.;
Mestroni, G.; Gladiali, S. Chem. Rev. 1992,1051.
a) Brown, J. M.; Bmnner, H.; Leitner, W.; Rose, M. Tetrahedron: Asym. 1991,2,331;
b) Saburi, M.; Ohnuki, M.; Ogasawara, M.; Takahashi, T.; Uchida, Y. Tetrahedron Len. 1992,33,
5783.
Cadierno, V.; Francos, I., Girneno, J.; Nebra, N. Chem. Commun. 2007,2536.

3.1.1 Project origin

There has been some interest in our group to isomerize geraniol to y-geraniol and
the thermodynamic concentration of geraniol to y-geraniol under various conditions has
been investigated.56For example, geraniol was converted to y-geraniol in 18%yield using
in MeOH at room temperature.
catalytic amount of [RUCI~((S)-(-)-~~~BINAP)]~/N(C~H~)~
At 45 "C, the amount of geraniol increased to 22%. However, as discussed above, in a
neat reaction at 140 "C, the reduced product, citronellol, was obtained in 27% yield and
50% ee (R) (Scheme 3.1).

Scheme 3.1: First Example of Ruthenium Catalyzed Asymmetric Transfer Hydrogenation
(ATH) of an Allylic
RU(II)(S)-~O~BINAP
MeOH
geraniol

gamma-geraniol
18% yield at 20 O C
22% yield at 45 O C

RU(II)(S)-~O~BINAP
Neat
140 OC, 3 days

citronellol
27% yield, 50% ee (R)

Soon after this initial result, extensive effort was put into the optimization of this
reaction. Based on previous literature references, it was decided to use isopropanol as
hydrogen donor and potassium hydroxide as base in the reaction. The focus of the
optimization work was to find a good mtheniudligand catalyst system, as well as, the

optimum temperature, which could result in higher yields and ee's. Table 3.1 summarizes
the results of some of the ligands screened in this reaction. Using 0.01 M geraniol in
isopropanol and a substratel[Ru(COD)C12]JKOH/ligandmolar ratio of 10/1/2.1/2, it was
demonstrated that (S)-tolBINAP (A, Figure 3.1) gave the best yield (95%) and
enantiorneric excess (90% ee) (entry 5, Table 3.1).

Table 3.1: Evaluation of Various Ligands in the ATH of GeranioLS6
Entry"

Ligand

Time (h)

%~ o n v . ~

% Citronellol
(% eec, Config.)

31 (0)

"0.01 M solution in P A , (geranioV[Ru(COD)C1~]&OH/ligand molar ratio = 10/112.11 ,
yields measured on a DB-5 column (J&W Scientific, 15 m x 0.32 mm). 'ee analysis
measured on the (R) Mosher ester on a Chiralcel 01-H column (Daicel, 250 mm x 4.6
mm). *78% isolated yield by column chromatography. e98 % dihydrocitronellol formed,
(geranioV[Ru(COD)Cl2]&OH/ligand molar ratio = 2/1/2.1/2).

b~~

The reaction with (S,S)-iPrDUPHOS (B, Figure 3.1) went to 100% conversion but
without regioselectivity (entries 7 and 8, Table 3.1). This ligand resulted in the reduction
of the second double bond of geraniol to give dihydrocitronellol (3,7-dimethyl-octan-1-

01). However, this result suggests that this ligand produces a more powerful catalyst
which is able to reduce functionalized and unfunctionalized alkene groups.

Figure 3.1: Ligands Used in Table 3.1 and Table 3.2.56

to1 BlNAP

iPr DUPHOS

DlOP

BlNAP

B

A

PHANEPHOS

Me DUPHOS

Ef BPE

Several substrates (Figure 3.2) were evaluated in this reaction using two of the
most reactive ligands, S-tolBINAP and (S,S)-iPrDUPHOS (Table 3.2). It has been
demonstrated that the allylic bond of several allylic alcohols (geraniol, nerol, 3-phenyl-2buten-1-01) can be converted to their saturated alcohols in excellent yields (95 - 99 %)
and moderate to good ee (72 - 93 %) with S-tolBINAP. Lower yields were obtained for
geraniol and nerol with iPr-DUPHOS, but this catalyst was proven to be the best for 3phenyl-2-buten-1-01. giving 99% yield and 93% ee. An a$-unsaturated carboxylic acid,
was also converted to the reduced product in excellent yield, but in low enantioselectivity
with both ligands. The reaction with 3-methylcyclohex-2-enone resulted in double

reduction of the olefinic and the carbonyl groups in high yield with both ligands (97 - 98
% yield), but the diastereoselectivity was significantly lower (4: 1, cis:trans) compared to

what was obtained from gaseous hydrogenation (1:3000 ~is:trans).~
Lastly, the reduction
of the double bond in trans-methylstilbene resulted in low conversion, only 18% in 24 h
(entry 11, Table 3.2).
Table 3.2: Transfer Hydrogenation with RuItolBINAP (A) and RuIiPrDUPHOS ( B ) . ~ ~
Entrya

Substrates

Ligand

Time (h)
(% convb)

% productb
(% ee, config)"

A

2 (100)

95 (90, R)

1
geraniol

-

.

B

2

50 (80-84, R)

2 (100)

.-

..

9
10

3-methylcyclohex-2enone

11

trans-methylstilbene

....- . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

.
.
.

I

.

24 (18)
I

I

-

23 cis (17, S,R)
6 trans, (16, R,R)
34 cis (8, S,R)
9 trans (14,.........R,R)
18 (0)

I

'0.01 M solution in P A . lsubstratellRu~COD~C1~1fiOWlirrand
molar ratio = 10111
- . ,
2.1121. b~~ yields measuredwith a DB-5 column (J&W Scientific, 15m x 0.32mm). 'ee
analysis of entries 1-4 measured on the (R) Mosher ester on an OJ-H column; ee analysis
of entry 5 and 6 measured on the acetate on an OJ-H column; ee analysis of entries 7,8
and 11 measured directly on an OJ-H column; ee analysis of entries 9 and 10 measured on
the (R) Mosher ester where the ee of the cis isomer was measured by GC analysis on a
DB-23 column (J&W Scientific, 15m x 0.32mm) and the ee of the trans isomer was
measured by proton decoupled
NMR. '2.5 equiv. of KOH per substrate was used.

Figure 3.2: Substrates Used in Table 3.2?

2-pheny -2-butenoc
ac d

?-methy -2cyc ohexenone

trans-methy st bene

It is worth noting that the configuration of the products obtained from nerol and
geraniol were consistent with the gaseous hydrogenation; but the result for 3methylcyclohex-2-enone, which gave a very low stereoselectivity, clearly indicated that
our system was different. Therefore, it was imperative to understand the mechanism of
our system.

3.1.2 Project Goals
The main objective of this project was to understand the mechanism of this
interesting and potentially useful rutheniundBINAP asymmetric transfer hydrogenation
(ATH) reaction. To meet this objective, the effects of various hydrogen donors, including
cyclic and chiral alcohols, at different concentrations and temperatures have been studied.
The asymmetric transfer hydrogenation of a homoallylic alcohol, y-geraniol, has been

conducted and compared to the result of the gaseous hydrogenation reaction. The effects
of a commercial catalyst, [(S)-BINAPIRu(QC12, which may have a similar structure to
our in situ-prepared catalyst@, has been investigated. In addition, we have studied the
isomerization of geraniol in the absence of a hydrogen donor and with a deuterated donor.

3.2 Results and Discussion
3.2.1 Asymmetric Transfer Hydrogenation with Mixed Solvents
Using

the

optimized

conditions

with

0.01

M

geraniol

with

a

substrate/[R~(C0D)C12]~IKOW(S)-tolBINAP
molar ratio of 10/1/2/2, several solvents
were screened for effectiveness in the ATH reaction. Since the purpose of the isopropyl
alcohol (PA) is to transfer hydrogen in the reaction, we wanted to investigate the effects
of different solvents while using P A as a reagent. Thus, we added >I00 equiv of P A to
serve as the reductant.
As shown in Table 3.3, the reactions in dimethylformarnide (DMF), tert-butanol
and toluene (entries 2 - 4) resulted in 85 to >99 % conversion. However, the downside of
these reactions is that they all resulted in lower ee and the conversions were very slow.
These results clearly indicate that the large excess, such as complete use of the IPA as a
solvent, is needed for faster conversion and higher ee.
There seems to be a direct relation between the rate of conversion and the
enantioselectivity. Although a large excess IPA (112 equiv) is being used in these
reactions, the conversion of geraniol to citronellol in the mixed solvents media is very
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slow. In some cases, for example in 1,2-dimethoxyethane (entry 6, Table 3.3), the
reaction went to only 2% conversion.

Table 3.3: Transfer Hydrogenation with RuItolBINAP in Mixed Solvents.

+

0

+

j;,

[RuCODCI~],
(S)-lolBINAP
geraniol

KOH
sobent, 100 O C

citronello,

acetone

*Reaction performed at 40 OC.
"GCconversions measured with a HP-5 column (J&W Scientific, 15 m x 0.32 mm).
#
ee measured on RT-BetaDEXsa GC column, 30 m x 0.32 mm ID x 0.25 mm.
b
ee measured by derivatization with Mosher acid chloride

The amount of IPA in the reaction may be important in the conversion rate.
However, since the conversion is different with different solvents, there might be a
solubility issue or a solvent interaction with the catalyst system. If any of the reagents,
KOH, (S)-tolBINAP, or [Ru(COD)C12],, have low solubility in the solvent, that will

result in slower conversion. In addition, if the solvents have greater affinity for the
catalyst than P A , that may result in less reactive sites for the reaction to occur, thus
slower conversion.
Why would a slower reaction rate affect the enantioselectivity? It is well known
that transfer hydrogenation with P A is a reversible process.20a At low IPA
concentrations, the en01 intermediate (0in our proposed mechanism (Scheme 3.12) may
go back to the allylic intermediate (b). Depending on the conformation of the reversibily
formed allylic intermediate (cis or trans), the (S) or the (R) product may be obtained. This
point will be further clarified when the proposed mechanism is discussed in Section 3.2.8.
We've already demonstrated that asymmetric transfer hydrogenation of geraniol (trans)
and nerol (cis) with (S)-tolBINAP gives opposite configurations of citronellol (Table 3.2,
entries 1 and 4). Similarly, transfer hydrogenation of the cis and trans isomers of the
reversibily formed allylic intermediate (b in Scheme 3.12) gives both (S) and (R)
citronellol, which results in lower ee. Therefore, slow reactions give lower ee's.
The reaction didn't go in methylene chloride (entry 5, Table 3.3), however, this is
likely due to the lower temperature used, 40 "C. In 1,2dimethoxyethane (entry 6, Table
3.3), the reaction went to only 2% conversion after 117 hours at 100 "C. This is an
example of a solvent that has strong affinity for the catalyst. The oxygens in the 1,2dimethoxyethane may chelate the ruthenium center to give the inactive catalyst I1 below.
A similar diamine catalyst to 11, Ru-(S)-XylBINAP-DAIPEN (I), has been reported to be
very active in the reduction of carbonyl groups under gaseous and transfer hydrogenation

condition^.^. I5The nitrogen groups in the diamine catalyst are believe to take part in the
hydrogenation process (metal-ligand bifunctional mechanism Figure 1.9). This
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mechanism doesn't involve coordination of the substrate to the metal center. The
hydrogenation is believed to take place via a six-membered ring transition state
intermediate (Figure 1.9). If I1 is generated with l,Zdimethoxyethane, it may not be able
to catalyze the isomerization step of the allylic alcohol to the carbonyl prior to transfer
hydrogenation, which we are proposing as the mechanistic route of our ATH reaction
(Section 3.2.8). The isomerization step requires coordination of the substrate to the metal
center.

Ru-(S)-XylBINAP-DAIPEN
(1)
Active

3.2.2 Asymmetric Transfer Hydrogenation with a Cyclic Alcohol Donor
Another study we wanted to conduct was the effect of a cyclic hydrogen donor in
our system. Cyclohexanol was selected because of its high melting point of 20 - 22 "C.
Its use in our reaction as a hydrogen donor would eliminate the cryogenic conditions
needed to freeze P A (m. p. = -89.5 "C) during the degassing process. The required
freeze-pump-thaw could easily be done in an ice-water bath instead of the liquid nitrogen
bath used for P A .

Table 3.4: Transfer Hydrogenation with Ru/(S)-tolBWAP in Cyclohexanol,

[RuCODCI~],
(S)-tolBINAP
KOH
geraniol

citronellol

cyciohexanone

'~euterated cyclohexanol.
%C conversions measured with a HP-5 column (J&W Scientific, 15 m x 0.32 mm).
beemeasured on RT-BetaDEXsa GC column, 30 m x 0.32 mm ID x 0.25 mm.

Using our best conditions (substrate/[Ru(COD)Cl~],,/KOW(S)-tolBINAP
molar
ratio = 10/1/2/2), we conducted the reactions in 0.01 M geraniol in cyclohexanol. The
results are summarized in Table 3.4. To have a direct comparison with P A , the first
reaction was set at 100 "C for two hours (entry 2). This reaction went to only 4%
conversion and the ee wasn't determined.

To increase the conversion, we decided to increase the temperature of the
reaction. At 160 "C (entry 4), the reaction went to 92% conversion in 4 hours and the ee
was 66%. At a higher concentration, 0.02 M (entry 5), the reaction went to 100%
conversion in 4 hours, but the ee dropped to 26%. This is a very clear example that
higher concentration results in lower ee. However, this trend doesn't seem to continue
beyond 0.02 M concentration. At 0.1 M concentration, the ee remained at 24% (entry 6).
Entry 7 shows the reaction with dxz-cyclohexanol at 0.1 M concentration which was
conducted in an 8 hour reaction time. This reaction results in lower ee (1 1%) than the
non-deuterated reaction at the same concentration (entry 6). This might be the result of
the difference of reaction time or subtle differences in cyclohexanol versus ducyclohexanol.

3.2.3 The Effects of Chiral Alcohol in Asymrnehic Transfer Hydrogenation
The use of chiral solvents in asymmetric synthesis is well known.65 For example
Vo-Thanh reported a Baylis-Hillman reaction of benzaldehyde and methyl acrylate in the
presence of a chiral ionic liquid to give the alkoxyester in 44% ee (Scheme 3.2)." The
chirality of the product came from the ionic liquid solvent, which was the only source of
chirality in the reaction. Likewise, we wanted to investigate the effect of a chiral solvent
in the enantioselectivity of our ATH reaction.
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a) Baudequin, C.; Baudoux, I.; Levillain, I.; Cahard, D.; Gaumont, A.C.; Plaquevent, I. C. Tetrahedron:
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Scheme 3.2: Baylis-Hillman Reaction with Chiral Solvent.
DABCO, 30 OC
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To conduct this study, we selected 2-pentanol, which was used as solvent as well

as hydrogen donor in the reaction. The solvent 2-pentanol was selected to conduct this
study because of the following reasons: first, the (S) and (R) enantiomers are
commercially available; second, it is the closest secondary alcohol to P A that has a
higher melting point (-50 "C) than P A (-89.5 "C), 2-butanol has a melting point of -115
'C. The use of 2-pentanol allowed the freeze-pump-thaw process in dry icelacetone bath
(-78 "C) instead of the liquid nitrogen bath used for P A .
Using 2-pentanol, we ran the reactions at 0.01 M concentration of geraniol and a

substrate/[Ru(COD)Cl~]~lKOH/(S)-tolBINAP
molar ratio of 10/1/212. The results are
summarized in Table 3.5. The reaction in racemic 2-pentanol went to 84% conversion
and 79% ee at 100 "C in 2 hours (entry 1, Table 3.5). At 120 "C, the reaction with
racernic 2-pentanol went to 98 - 100 % conversion and 77% ee in 4 hours (entry 2, Table
3.5). This ee result was promising as it suggested that there could be improvement if a
pure chiral2-pentanol was used.

Table 3.5: Asymmetric Transfer Hydrogenation with Chiral Solvents.

KOH

geraniol
Entry

1

Solvent

(

citronellol

Temp. ("C)

(

Time (h)

2-pentanone

1

%

con^.^

I

eeb(R)

3

(S)-2-pentanol

120

2

86

72

4

(S)-2-pentanol

120

4

100

69

5

(R)-2-pentanol

120

2

50

2

6

(R)-2-pentanol

120

4

100

26

'GC conversions measured with a HP-5 column (J&W Scientific. 15 m x 0.32 mm).
~ ~ sx a0.32 mm ID x 0.25
bee analysis measured with a GC Column R T - ~ e t a ~30
mm.

m

The reaction with (S)-2-pentanol gave 86 - 100 %conversion and 69 - 72 % ee in
2 - 4 hours at 120 "C (entries 3 and 4, Table 3.5). The reaction with (R)-2-pentanol was
slower and resulted in only 50% conversion and 2% ee after 2 hours (entry 5, Table 3.5)
compared to the 86% conversion obtained with (S)-2-pentanol. This reaction went to
100% conversion and 26% ee in 4 hours under the same conditions (entry 6, Table 3.5).
These results indicate a striking difference in the selectivity of (S)-2-pentanol versus (R)2-pentanol with the Ru/(S)-tolBINAP catalyst system as (S)-2-pentanol is a better match.
Although we were hoping that the ee would increase with a properly matched chiral
84

solvent, we found that racemic 2-pentanol is as efficient as the (S)-2-pentanol, therefore
there is no advantage of using a c h i d solvent as the hydrogen donor.
It is also worth noting that the reactions with the (S) and (R)-2-pentanol were
conducted in a much lower scale (118) of the one with racemic 2-pentanol. It was difficult
to measure some of the reagents at that scale. This might be the reason why the ee from
the (S)-2-pentanol is slightly lower rather than being equal to what was obtained from
racemic 2-pentanol.

3.2.4Asymmehic Transfer Hydrogenation with Pre-Made Catalyst, [(S-)BZNAP)l
Ru(ZZ)Cl~
Since the catalyst cocktail method of combining [RuCODC12], with (S)-tolBinap
leads to an imprecisely defined catalyst precursor, we were interested in performing the
asymmetric transfer hydrogenation with a pre-made catalyst with known structure. Our
Ru/(S)-tolBINAP catalyst is prepared in situ from commercially available ruthenium
cyclooctadiene dichloride polymer, [RuCODClz],, and (S)-tolBINAP, which presumably
forms [(S)-tolBINAP]Ru(K)CIZ,complex A shown in Scheme 3.3. In the presence of (R)BINAP, the catalyst species would then be [(R)-BINAP]Ru(II)Clz, complex B in Scheme
3.3. These structures were supported by Ikariya who demonstrated that a dimer of
complex B, RuzCL[(-)-BINAP]z(N&), can be obtained with similar starting materials in
the presence of triethylamine in refluxed toluene.64 According to Ikariya, the dimer
should provide a co-ordinatively unsaturated ruthenium species, RuC12L2(L= phosphine
ligand), which is similar to our proposed complexes A and B. Also, the dimer, Ru2C14[(-)-

BINAP]2(NEt& is known to exhibit excellent catalytic acitivity and high stereoselectivity
for the hydrogenation of a,a-unsaturated amino acids (Scheme 3.4).64
To investigate that the structures of our in situ prepared catalysts are complexes A
and B (Scheme 3.3), we tried our ATH reaction with a commercially available catalyst,
[(S)-BINAP]Ru(II)C12, complex C in Scheme 3.3. This catalyst has the same
configuration as our in situ prepared catalyst A, but they are slightly different chemically
because of the difference between a tolyl-substituted ancillary group and a phenyl group.
To have a more exacting comparison, the results obtained with the commercial catalyst C
will be compared to the reaction with [RuCODC12]d(R)-BINAP, entry 6 in Table 3.1.

Scheme 3.3: Chemical Structures of [(S)-tolBINAP]Ru(II)C12 (Complex A),
[(R)-BINAP[Ru(II)C12 (Complex B) and [(S)-BINAP]Ru(II)C12(Complex C).

(S)-tolBlNAPRu(ll)CI2
complex (A)

(R)-BINAPRu(II)CI~
complex (0)

Commercially Available
(S)-tolBINAPRu(ll)C12
complex (C)

Scheme 3.4: Hydrogenation of a$-Unsaturated Amino Acids with Ru2C14[(-).
BINAP]~(NE~L~).~~

Table 3.6: ATH with Pre-made Catalyst [(S)-BINAPIRu(QC12 (Complex C in Figure
3.3) Comppzd with in situ Prepared Catalyst B.
Cafa yt

or C

IPA KOH 1 C C OC

geran o

c trone o

acetone

concentrat~on

%C conversions measured with a HP-5 column (J&W Scientific, 15 m x 0.32 mm).
bee analysis measured with a GC Column RT-BetaDEXsa 30 m x 0.32 mm ID x 0.25
mm. 'ee analysis measured on the (R)-Mosher ester on a Chiralcel OJ-H column (Daicel,
250 mm x 4.6 mm). *GC conversions measured with a DB-5 column (J&W Scientific, 15
m x 0.32 mm).

It has already been demonstrated that tolBINAP gives slightly better
enantioselectivity than BINAP (Table 3.1). Here we want to compare the results from two
sterically similar RulBINAP catalysts: the pre-made catalyst [(S)-BINAP[Ru(II)C12 (C)
and our in

situ

prepared catalyst [(R)-BINAPIRu(QC12 (B). As shown in Table 3.6,

commercially available catalyst (S)-BINAPRu(Il)Clz (C) was able to fully convert
geraniol to (R)-citronellol in 90% ee (entry 2). This result is slightly higher than that
obtained from our in

situ

prepared catalyst B (87% ee) with, of course, the opposite

configuration. The commercial catalyst (C) was also able to convert nerol to (S)citronellol in 91% ee (entry 3). The only difference is that this catalyst offers the
advantage of maintaining the enantioselectivity at higher concentration. At 0.02 M and
0.1 M geraniol, catalyst C gives (R)-citronellol in 92.8% and 93.4% ee,respectively, with
a slightly increase in ee compare to the reaction at 0.01 M concentration. This is likely
due to a higher concentration of the "active" catalyst species that is obtained from the
pure precatalyst compared to what is obtained from the catalyst cocktail.
To further test the efficiency of the commercial catalyst, we decided to run a set of
experiments without the three freeze-pump-thaws. In this series, the IPA was degassed
with argon for 1 hour and the reagents were charged under argon. Under these conditions,
the pre-made catalyst, [(S)-BINAP[Ru(II)Clz, was able to give citronellol in 95%
conversion and 91.7% ee in two hours (Table 3.7). This kind of conversion was never
obtained under similar conditions with our in

situ

prepared catalysts. This suggests that

the cryogenic freeze-pump-thaw procedure is necessary for the preparation of the catalyst,
but not for the transfer hydrogenation reaction.

Table 3.7: ATH with Pre-made Catalyst [(S)-BINAP]Ru(II)C12.
[(S)-BINAP]RU(II)CI~
IPA, KOH,100 OC

-

geraniol

-

(R)-citronellol

Entry

Time (min.)

% con^.^

% eeb

1

30

80.3

93

2

60

80.5

91.6

3

90

88.5

92.2

4

120

95

91.7

-

aGCconversions measured with a HP-5 column (J&W Scientific, 15 m x 0.32 mm).
b

ee analysis measured with a GC Column RTBetaDEXsa 30 m x 0.32 mm ID x 0.25

mm.
In Table 3.7, we explore the effect of reaction time on reaction conversion and ee.
Each data point in Table 3.7 represents a separate reaction. Like with the in situ prepared
catalyst, attempts to sample the reaction mixture result in deactivation of the catalyst.
That is additional evidence suggesting the structural similarity between the commercial
and the pre-made catalysts.

3.2.5 Asymmetric Transfer Hydrogenation of pGeraniol

In gaseous hydrogenation, there is a reciprocal relationship between nerol and
geraniol. These two substrates give opposite configuration of citronellol after
hydrogenation with either (S) or (R) RuIBINAP catalyst (Scheme 3.5).3 A similar
observation was made in our transfer hydrogenation system (Table 3.1, entry 5 and 6 and

Table 3.2, entry 1 and 3). In contrast, in the presence of the (S)-RuIBINAP, y-geraniol
gives (S)-citronellol in 85 - 93 % ee (Scheme 3 . ~ ) . ~We
' wanted to investigate if this
relation also exists in our transfer hydrogenation system.
Since y-geraniol is not commercially available, we prepared it following the
conditions shown in Scheme 3.6.68 The reaction is a one-pot synthesis, which involves
the in sifu preparation of disiamylborane (31) stating with commercially available
isoprene (30).Treatment of 31 with myrcene gives the the trialkylborane (32), which
subsequently hydrolyses to the crude product. Purification of the crude by fractional
distillation gives y-geraniol(33) in 15%yield and 97% purity (GC area percentage).

Scheme 3.5: Reciprocal Relationship Between Nerol and Geraniol.
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Scheme 3.6: Preparation of y-Geraniol.
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Attempts to perfom transfer hydrogenation of y-geraniol under our best
conditions with substrateI[Ru(COD)Cl&,KOH/(S)-tolBINAP

molar ratio = 10/1/2/2,

result in 40.7% conversion to citronellol after 2 hour at 100 "C. Prolonged heating of the
reaction mixture for up to 6 hours results in 50.6% conversion to citronellol (Table 3.8).
As usual, each data point represents a separate reaction; attempts to withdraw samples
from the ongoing reactions result in deactivation of the catalyst.
An interesting observation we made in the transfer hydrogenation of y-geraniol
with two equiv of base (that is, with respect to the catalyst load) is the formation of small
amounts of nerol and geraniol in every reaction. With two equiv of base, the amount of
geraniol formed in every reaction exceeds the amount of nerol formed; as a result the (R)citronellol is obtained in a small excess (19 - 34 % ee). Thus, y-geraniol gives low ee
under ATH conditions and the chiral direction is different from that of the hydrogenation
reaction, 85 - 93 % ee (S). In fact, the chiral direction seems to correlate with the slight
excess of geraniol detected in the reaction.

Table 3.8: Asymmetric Transfer Hydrogenation of y-Geraniol with Two Equivalents of
Base.
+Y-geraniol
+%

nerol

t%geraniol
*%

.

7

0

30

120

240

citronellol

*

360

Time (min.)

I I
Time

(mi@

ygeraniola
(GC a m 8)

I

nerola
geraniola
(GC area ~ a ) (GC area %)

~

I

citronellola
(GC a m %)

1

% eeb
(R )

I

-

32.84
2.33
360
49.4
36.17
8.13
"GC conversions measured with a HP-5 column (J&W Scientific, 15 m x 0.32 mm).
bee analysis measured with a GC Column RT-BetaDEXsa 30 m x 0.32 mm ID x 0.25
mrn.

In an attempt to increase the conversion of y-geraniol, the amount of base was
increased to four equiv. with a substratd[Ru(COD)CI&IKOW(S)-tolBINAP molar ratio
of 10/114/2. In two hours, the reaction went to 87.93% conversion; more than double of
the percent conversion obtained with two equiv of base over the same period of time. On
the other hand, the amount of (R)-citronellol produced in every reaction decreases in a
manner that directly corresponds to the lower amount of geraniol and increasing amount
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of nerol produced in the reactions with four equiv of base. This set of experiments results
in very low ee, which shifts from 9.72% (S) to 8.2% (R) citronellol (Table 3.9).

Table 3.9: Asymmetric Transfer Hydrogenation of y-Geraniol with Four Equiv of Base.

tY-geraniol
4- % nerol

15

0

60

30

120

240

360

Time (min.)

0

96.71

0

0

0

N/A

15

45.03

1.13

1.21

44.53

4.18 (S)

30

24.7

1.46

1.04

59.42

9.72 (S)

12.07

120
I

-

0.24

0.57
I

7.44 (S)

64.17
I

I

I

240

21.71

1.39

0.76

60.69

1.72 (R)

360

12.82

1.41

0.88

64.18

8.2 (R)

a

GC conversions measured with a HP-5 column (J&W Scientific, 15 m x 0.32 mm).
ee analysis measured with a GC Column RT-BetaDEXsa 30 m x 0.32 mm ID x 0.25
mm.
b

Our results indicate that ATH of the homo-allylic alcohol y-geraniol is possible,
however, the reaction is relatively slower compare to the ATH of nerol and geraniol and
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the enantioselectivity obtained is very low and sensitive to the concentration of base. This
leads us to believe that the mechanism of our ATH system is different from the gaseous
hydrogenation. In addition, all the reactions with y-geraniol generate small amounts of
nerol and geraniol. Therefore, we think that the ATH of y-geraniol may take place via
isomenzing to nerol and geraniol prior to ATH. Knowing that the ATH of nerol and
geraniol give opposite configuration of citronellol (S) and (R), respectively, isomerization
of y-geraniol to both nerol and geraniol prior to ATH would result in what we observe in
our experiments; low enantioselectivity.

3.2.6 Zsomerization of Geraniol

Transition metal catalyzed isomerization of allylic alcohols to carbonyl
compounds is well known.69 Many examples of primary, secondary and cyclic alcohols
have been reported to oxidize under intramolecular redox processes. The earliest
examples of allylic alcohol isomerization were reported by Botteghi and Giacomelli in

1 9 7 6 . ~ ~These
'
examples had limited success in terms of conversion and
enantioselectivity. For example, HRh(CO)(PPh3)3/DIOP catalyses the isomerization of 2methylbut-2-en-1-01 to the corresponding aldehyde in 98% conversion and 4% ee. A
similar reaction resulted in 0%conversion when there was a phenyl group attached on the
allylic bond (Table 3.10).

69

a) Ito, M.; Kitahara, S.; Ikariya , T. J. Am. Chem. Soc. 2005,127 (17), 6172; b) Drift, R. C. van der;
Bouwman, E.; Drent, E. J. Organomet. Chem. 2002,650, 1 ; c) Uma, R.; Crvisy, C.; Gre, R. Chem. Rev.
2003,103 (I), 27; d) Slugovc, C.; Rba, E.; Schmid, R.; Kirchner, K. J. Organomet. Chem. 1999,18 (20),
4230.

Table 3.10: Asymmetric Isornerization of Allylic Alcohols with HRh(CO)(PPh&/JXOP
Catalyst

Scheme 3.7: Asymmetric Isornerization of Geraniol with Rh-BINAP.70.71

geraniol

S-citronellal
70% yield, 37% ee

diethylgeranylamine

R-citronellal enamine
100% yield, 96-99% ee

Another example includes cationic-Rh-BINAP catalyzed isomerization of geraniol
to citronella1 in 70% yield and 37% ee (Scheme 3.7).70 This yield is considerably lower

O'

Tani, K. Pure &Appl. Chem. 1985,57, 1845.
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compared to the excellent yield obtained with the corresponding allylic amines; the major
step in the industrial synthesis of menthol and other terpenes, which proceeds in 100%
yield and 95 - 99 % ee.71
The mechanism of the isomerization of geraniol to citronellal is believed to
proceed via the same route as the isomerization of geranylamine, where the nitrogen atom
plays an important role.7' There is no experimental evidence on how the hydrogen
transfer takes place, but two types of mechanisms have been proposed (Figure 3.3).69c
The type I mechanism takes place via an alkylmetal intermediate. In this case, the
catalyst is a metal-hydride [M-HI, which is either isolated or generated in situ. The type

II mechanism takes place via a x-ally1 intermediate. In this case, the transition metal [MI
leads the migration of the hydrogen from position 1 to position 3 of the allylic alcohol via
a x-ally1 metal hydride intermediate.

In our system and the presence of a hydrogen donor, geraniol is converted to
citronellol; the aldehyde citronellal has never been detected in the reactions using the
ATH conditions of catalyst, hydrogen donor and base. To see if isomerization was taking
place in our ATH reactions, we decided to run a reaction in the absence of the hydrogen
donor, P A . The isomerization reaction was conducted in t-butanol, a non-oxidizable
alcohol. Using a substratel[Ru(COD)C12]JKOW(S)-tolBINAP molar ratio of 10/1/2/2,
geraniol (1) was converted to citronella1 (34) in 21% yield (Scheme 3.8). This reaction
also gave citronellol(2) in 13% yield and 77% ee. This result is reminiscent, vide supra,
to the origin of this project where geraniol acts as a hydrogen donor to give citronellol in

71

Otsuka, S.; Tani, K.Synthesis 1991, 665

27% yield and 50% ee (Scheme 3.1). In this reaction, we were able to identify all the
major components of the isornerization reaction: the isomerized product citronella1 (34),
the reduced product citronellol (2) and the oxidized product citral (35), which was

-

obtained in equal amount as citronellol, 13% yield.

Figure 3.3: Proposed Mechanism for Asymmetric Isomerization of Allylic
Alcohols.
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Scheme 3.8: Asymmetric Isomerization of Geraniol.
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In an attempt to prevent the transfer hydrogenation from occurring, we repeated
the isomerization reaction without base, but, this resulted in 0%conversion (Scheme 3.8).
Isomerization of geraniol to citronellal is possible with our Ru-BNAP catalyst system.
However, the isomerized product was never detected in our reaction system. If citronellal
is an intermediate, it may be rapidly hydrogenated in the presence of the hydrogen donor,
PA.

3.2.7 Deuterium Experiments
To investigate which pathway our asymmetric transfer hydrogenation follows, we
conducted a series of deuteration experiments. These will provide two key answers: first,
the transfer of deuterium to the substrate will confirm that the alcohol is the hydrogen
source in the reaction, second, the position of the deuterium on the reduced product will

tell which path the reaction follows. Some of the possible outcomes of the deuterium
experiment are highlighted in Scheme 3.9.

Scheme 3.9: Potential Products from the ATH with Deuterated P A .
Via direct allylic

Product A

Via isomerization with a metal deuteride (M-DJ, metal ligand intermediate
Dj o D

M-D

R
a

*

R

I

-

R
D
Product B

Product C
Via isomerization with a metal (M), *ally1 isomerization

I

Product D

Product E

For simplicity, we are leaving the possibility of deuterium exchange until later. If
the reaction goes via direct hydrogenation of the C=C, the deuteriums will transfer
directly across the double bond of the allylic alcohol and product A will be formed
(Scheme 3.9). If the allylic bond isomerizes to the enol, via the Type I M-H mechanism
proposed in Figure 3.3, prior to transfer hydrogenation, product B will be formed. Under
the same isomerization pathway, if the en01 tautomerizes to the aldehyde prior to transfer
hydrogenation, product C will be formed. However, if the isomerization takes place via
the Type I1 x-ally1 mechanism in Figure 3.3, transfer hydrogenation of the en01 and the
aldehyde will give products D and E, respectively.
Using our optimum conditions, substratel[R~(COD)C1~]JK0W(S)-tolBINAP
molar ratio = 10/1/2/2, the asymmetric transfer hydrogenation of geraniol was conducted
in ds-isopropanol to give d3-citronellol (36) in 86% yield and 98% ee (Scheme 3.10). This
product was characterized by GUMS and various NMR experiments.

Hp

Scheme 3.10: Asymmetric Transfer Hydrogenation of Geraniol with Deuterated IPA.
[RWOD)C1dn
S)-tolBlNAP
KOH
dB-IPA
100 "C, 4 h

+

1

36

geraniol

d3-citronellol
86% yield, 97.8% ee (R)

This experiment answers our first question regarding whether transfer
hydrogenation took place. The GCIMS of the product shows a mass of 159, which
indicates the formation of d3-citronellol (Figure 3.4). The presence of deuterium on the

product indicates that deuterium did transfer from ds-PA to geraniol, giving d3citronellol.
The second question on how the transfer hydrogenation occurs will be answered
in the following discussion. The proton NMR of the product (Figure 3.5) shows a signal
at 3.64 - 3.67 ppm that integrates as 0.98. This indicates the absence of one proton or the
presence of one deuterium on C1. In regular citronellol, that signal integrates for two
protons. In addition, the signals of the C3' protons at 0.89 - 0.92 ppm, which integrates as

3.2, and occurs as show a doublet. The multiplicity of the C3' protons indicates the
presence of one proton (no deuterium) on C3, which eliminates the possibility of direct
addition of hydrogen to the C=C.

F i r e 3.4: Segment of GCIMS of d3-citronellol.

Figure 3.5: The 'H NMR of d+itronellol.
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I3cNMR shows a tremendous supression of C1 and C2 (Figure 3.6). This

indicates the presence of deuterium at these two locations. Furthermore, deuterium
couples with carbon, as a result the deuteriumcarbon peaks will split. Sure enough, a
closer look at C1 (Figure 3.7) reveals a triple with a J ~=D21 which matches the literature
reference for the CD coupling constant ( J ~ D
= 20-30

Thus, this confirms the

presence of one deuterium on C1. A closer look at C2 (Figure 3.7) shows a multiplet.
Since the deuteriums on C2 are diastereotopic (alpha to the chiral center), it is reasonable
to suggest that the multiplet is an overlap of two triplets; a typical pattern for CDD'. The
13

C NMR clearly indicates the location of the three deuteriums on our d3citronellol.
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Figure 3.6: I3cNMR of d3-citronellol.
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Figure 3.7: Enlarged I3cNMR of dTcitronellol.
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To confirm the absence of protons on C2, we decided to run an HMQC NMR of
our d3citronellol and compare this spectrum to that of regular citronellol. HMQC

(Heteronuclear Multiple-Quantum Coherence) is a two-dimensional inverse protoncarbon correlation technique.73 This NMR experiment is selective for direct C-H bonds.
Therefore, every carbon that is directly attached to a hydrogen (but not a deuterium) will
show a correlation. In the enlarged HMQC spectrum of citronellol (Figure 3.9), we see
the correlations for the two diastereotopic protons on C2. These two correlations are
reduced to a trace signals in our d3-citronellol product (Figure 3.8).

Figure 3.8: Enlarged HMQC NMR of d3-citronellol.

A more direct analysis of the d3-citronellol is the 'H NMR shown in Figure 3.10.
Integration of the 3.64 ppm deuterium of C1 for I deuterium results in simultaneous
integration of the 1.34 and 1.56 ppm deuteriums of C2 as 1.61 deuteriums which is close
to the expected value of 2 deuteriums. This result confirms that the major product formed

73 Silverstein, R. M.; Webster, F. X. Spectrometric Identification Of Organic Compounds, 6th Ed., John
Wiley & Sons: New Yolk, 1998.
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from our ds-PA experiment is indeed compound 36 in Scheme 3.8. The two small
signals at 0.86 and 1.1 ppm do not seem to be related to the product.

Figure 3.9: Enlarged HMQC NMR of Regular Citronellol.
HQCGP C W 1 3

D:\\ N% 5 9

Figure 3.10: 'H NMR of d3-citronellol.

The position of the deuterium on the product helped us determine which pathway
the hydrogenation followed. Going back to Scheme 3.9, we can eliminate the first three
possibilities, since our product (36) doesn't have any deuterium on C3. Therefore, we can
say that neither direct hydrogenation of the C=C bond, nor a Type I metal hydride (M-H)
isomerization followed by transfer hydrogenation is the mechanistic route of our system.
The isomerization in our system must have been taken place via the Type I1 x-ally1
mechanism (Scheme 3.11). The en01 then leaves the catalytic cycle and undergoes
tautomerization in the presence of the deuterated solvent to generate the aldehyde, which
reenters the catalytic cycle for transfer hydrogenation.

Scheme 3.11: Isomerization/ATH of Allylic Alcohols Via rc-Allyl Mechanism with
d8-PA.
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Scheme 3.12 summarizes the mechanism of the ATH reaction. Starting with the
allylic alcohol a, a base generates the alkoxide b, which coordinates to a selective side of

the ruthenium complex to produce c. A x-ally1 intermediate d is generated, which
subsequently undergoes a metal-mediated 1,3-hydrogen shift (the chiral induction step) to
give the chiral intermediate e. p-elimination releases the chiral en01 f. This concludes the
isomerization part of the process. In the presence of a deuterated alcohol (DOR), the en01
f undergoes deuterium exchange follow by tautomerization, which enables incorporation

of deuterium on C2 to give the aldehyde g. Transfer hydrogenation of g follow by an
aqueous workup gives the d3-citronellol product h. This experiment clearly indicates the
isomerization as the chiral induction step. Remarkably the direction of chirality is the
same as the gaseous hydrogenation even though the mechanism is different from what
occurs in gaseous hydrogenation.3

Scheme 3.12: Proposed Mechanism for Asymmetric Transfer Hydrogenation.

It is unclear if all these steps are reversible. However, it is well known that
transfer hydrogenation with P A is a reversible process.208In addition, our experiments in
low P A concentration, which are slow in conversion rate, result in lower ee. This leads
us to believe that under low P A concentration or low hydrogen dogor concentration, the
aldehyde g, which is in equilibrium with f, goes back to the alkoxide b. During the
reverse process, the alkoxide may switch from the original trans to cis configuration. This

might be the source of the low enantioselectivities obtained in the reactions with low P A
concentrations (Table 3.3) or the slow reactions with cyclohexanol and 2-pentanol
(Tables 3.4 and 3.5).
We do have evidence that our ATH reaction mechanism involves isomerization of
the allylic bond to aldehyde prior to hydrogenation. Both steps, the isomerization of
allylic alcohols to aldehydes69.

70

and the transfer hydrogenation of carbonyls to

alcohols,28, 31, 32 have been reported. However, none of these reports has mentioned the
reduction of an allylic alcohol. In addition, the isomerized product was never detected in
our reaction mixtures. Yes, we do have isomerization prior to ATH, but we could not
make this distinction if we did not perform the mechanistic study. Our observation is that
allylic alcohols undergo asymmetric transfer hydrogenation in the presence of RulBINAP
and P A as hydrogen donor.

3.3 Conclusions
In conclusion, asymmetric transfer hydrogenation of allylic alcohols is possible
and the product can be obtained in high yield and excellent enantioselectivity. The yield
and the chiral direction of the product is the exact same as the gaseous hydrogenation
catalyzes the asymmetric transfer
reaction. For example, [RuCODC12],,/(S)-tolBINAP
hydrogenation of geraniol to (R)-citronellol in 90 - 95 % yield and 95 - 98 % ee. This
yield and enantioselectivity rival gaseous asymmetric hydrogenations of allylic alcohols.
However, a significant advantage of this ATH reaction is that it eliminates the high
hydrogen pressures (>30 atmP used for the same transformation.

This asymmetric transfer hydrogenation reaction is not limited to isopropanol as
hydrogen donor. Other alcohols, such as racemic and chiral 2-pentanol and cyclohexanol,
can also be used. In our study with the 2-pentanol, we have demonstrated that a chiral
solvent is not required to enhance the enantioselectivity. The racemic alcohol can provide
the same enantioselctivity as the most active chiral alcohol. In our study with
cyclohexanol, we have demonstrated that the freeze-pump-thaws can be done under noncryogenic conditions. The freeze-pump-thaws can be done at the melting point of the
solvent used.
catalyst
Most of our experiments are done with the [RuCODC12],,/(S)-tolBINAP
system as it gave the best yield and the best ee during our screening process. However,
other ligands including BINAP, (S,S)-MeDUPHOS and (S,S)-iPrDUPHOS can also be
used. In addition, we have demonstrated that a pre-made catalyst, [(S)-BINAP]Ru(iI)CI2,
can work efficiently in our system. This catalyst gives the same yield and chiral
configuration as our in situ prepared catalyst; which suggests that the structure of our
active catalyst may also be a [BINAP]Ru(II)Cl2 complex. Other experiments with this
catalyst without the freeze-pump-thaws resulted in no major changes in yield, ee and it
was possible to increase in substrate to catalyst ratio without affecting ee. Therefore, the
freeze-pump-thaw process is required only for the in situ preparation of the catalyst.
Our deuterium experiment indicates that the mechanism occurs through an
isomerization process, which is very different form the gaseous hydrogenation
mechanism. Considering that the yield, the chirality and the ee of our product is the exact
same as the gaseous hydrogenation, and given the fact that transfer hydrogenation is a

safer procedure, this reaction is a potential route for asymmetric reduction of allylic
alcohols.

EXPERIMENTAL SECTION
I. Chiral Method Development
A) Derivatizafrafron
with Mosher Acid Chloride
Reagents
All

chemicals

were

purchased

from

Aldrich.

The

R-(+)-methoxy-

trifluoromethylphenylacetyl chloride had an optical purity of 98% and a GC assay of

98%. The 4-(dimethy1amino)pyridine (DMAP) and the triethylamine (TEA) were reagent
grades with chromatographic purities greater than 99%.

Chromatographic Conditions
The reaction was monitored by gas chromatography, Hewlett-Packard 5890 Series
I1 equipped with a flame ionization detector. The column used was a DB-5, J&W
Scientific, 15 m x 0.32 mm. The chromatographic conditions were: split mode inlet
(250:l). 250 "C; column temperature 60 - 175 "C at 3 'Umin, He flow 30 mumin, 15
psi; detector 250 OC; 10 pl injection. The diastereomeric purity was determined on a
Hewlett-Packard 1050 Series high performance liquid chromatography (HPLC). The
column used was a Diacel Chiralcel OJ-H, 250 mrn x 4.6 mm. The mobile phase was a
mixture of HPLC grade hexanes and ethyl alcohol (EtOH), 90:lO to 5050 EtOH:hexanes,
0.6 mumin, 20 minute gradient; room temperature; 210 and 220 nm. The diastereomeric
excess was calculated based of HPLC area percent of the R-Mosher-R-citronellyl ester
and R-Mosher-S-citronellyl ester.

Reaction Conditions
To an ice cold solution of citronellol (35 mg, 0.22 mmol) in 3.5 rnL
dichloromethane (DCM) at 0 OC, was added (R)-Mosher acid chloride (123.5 p1, 0.66

mmol), triethylamine (92 PI, 0.66 rnmol), and 4dimethylaminopyridine (2.7 mg, 0.022
mmol). The mixture was refluxed for 4 hours or until GC revealed less than 1%
citronellol. After cooling to room temperature (rt), hexanes (5 mL) was added and the
reaction mixture was washed with saturated sodium bicarbonate (NaHC03), water, 0.1
normal aqueous hydrochloric acid (HCI), and water, respectively. The organic was dried
over magnesium sulfate (MgS04), filtered, and then concentrated to a crude oil. Without
further purification, the crude oil was diluted in 1:l HPLC grade Et0H:hexanes and
analyzed by HPLC for diastereometic purity.

B) Derivatrkation with S-Naproxen

Reagents

The (S)-Naproxen was isolated from commercially available drug ~ l e v e @All
.
other reagents, the oxalyl chloride, the triethylamine (TEA) and the 4(dimethy1amino)pyridine (DMAP) were purchased from Aldrich with purities greater than

99%.
Analytical Conditions

The first step of the reaction (Scheme 2.3) was monitored by TLC using 85:15/
hexanes:acetone. The melting point of the acid chloride product (28) was compared to the
literature value (91 - 94 "C). The second step was monitored by GC for the disappearance
of citronellol (23) on a Hewlett-Packard 5890 Series II equipped with a flame ionization
detector.

A DB-5, J&W Scientific, 15 m x 0.32 mm column was used. The

chromatographic conditions were: split mode inlet (250:1), 250 "C; column temperature
60 - 175 "C at 3 "Clmin, He flow 30 mumin, 15 psi; detector 250 "C; 10 p1 injection.
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During the chromatographic purification, TLC was used to analyze the purity of the
fractions. Satisfactory separation was obtained using 7:3/ hexanesacetone plus I drop
phosphoric acid (&Pod) in the TLC analysis. The final product S-Naproxen-ester 29 was
characterized using a 500 MHz Varian NMR equipped with Inova software in deuterated
chloroform (CDC13). The relaxation time was 1 second for both proton and carbon
experiments, with 8 and 256 scans, respectively.
Reaction Conditions
Step I : Preparation of (S)-NaproxenAcid Chloride

Ten equiv of oxalyl chloride (1.41 mL, 13 mmol) was added to solid (S)Naproxen (300 mg, 1.3 mmol). The mixture was stirred at room temperature (rt) for 30
min and formed a solution. The excess oxalyl chloride was removed under reduced
pressure at rt. Four volumes of dichloromethane (1.2 rnL) were added, and then hexanes
(30 mL) was added in small portions. The mixture was chilled over ice for one hour to
allow precipitation of the product. The solvent was decanted and the product was dried
under nitrogen flow overnight to afford S-Naproxen acid chloride as a white needle
shaped product (280 mg, 88% yield, mp 91 - 94 "C).
Step 2: Preparation of (S)-Citronellyl-NaproxenEster

To a cold solution of citronellol (35 mg, 0.22 mmol) in 5 mL dichloromethane
(DCM) at 0 "C, (S)-Naproxen acid chloride (81 mg, 0.34 mmol), triethylamine (92 pl,
0.66 mmol), and 4-dimethylaminopyridine (2.7 mg, 0.022 mmol) were added. The
mixture was refluxed for 4 - 5 h or until GC revealed less than 1% citronellol. After
cooling to room temperature (rt), hexanes (5 mL) was added and the residual salt was
removed by filtration. The filtrate was concentrated to a crude oil, which was purified

through a silica gel plug using hexanes. The enriched fractions were combined and
concentrated to dryness. The diastereomeric purity was determined by

I3c NMR

in

CDC13.

C) Chiral GC
Analytical Conditions
All reactions were monitored by gas chromatography, Hewlett-Packard 5890
Series I1 equipped with a flame ionization detector. The column used was a HP-5, J&W
Scientific, 30 m x 0.32 mm. The chromatographic conditions were: split mode inlet
(250:1), 250 "C; column temperature 60 - 175 "C at 3 "Clmin, He flow 30 mumin, 15
psi; detector 250 "C; 10 p1 injection. The enantiomeric excess of the crude citronello1 was
measured using a RT -BetaDEXsa column, 30 m x 0.32 mm ID x 0.25 mm, obtained
from Restek. The Chromatographic conditions were as follow: inlet, split mode (50:1),
150 "C;column, isothermal 80 "C, He flow 30 mumin, 15 psi, 120 min; detector 150 "C;
10 pl injection.

II. Asymmetric Transfer Hydrogenation
General Procedure for Transfer Hydrogenation and Derivatization with Mosher Acid
Chloride
Reagents
Geraniol (trans-3,7-dimethyl-2,6-octadien-1-01)
(98% purity) dichloro-ruthenium(Q-1,5-cyclooctadiene complex, [RuCODC12],, (95% purity) and the ligand (S)-(-)-2,2'-

bis(di-p-toly1phosphino)-1,l'-binaphthyl, (S)-tolBWAP, 97% purity) were purchased

from Aldrich. The pre-made catalyst, dichloro-[(S)-(-)-2,2'-bis(diphenylphosphino-l,1'binaphthyl]ruthenium(II), [(S)-BINAP]Ru(lI)C12, was obtained from Strem in 95% assay.

Potassium hydroxide, technical grade, was purchased from Fisher. The solvents, 1,2dimethoxyethane and the N,N-dimethylforrnamide (DMF), each in anhydrous grade and
>99.5% assay were purchased from Aldrich. The hexanes and the ethanol, HPLC grade,
and all the other solvents (isopropanol, t-butanol, toluene, dichlorornethane,
cyclohexanol, 2-pentanol), were purchased as ACS Grade solents from Fisher. The
enantiomers of 2-pentanol, 98% assay, were purchased from Aldrich with optical
activities of [ a I z 5of
~ +13" (S) and -13" (R). The deuterated solvents, ds-isopropanol, dl2cyclohexanol and dl-chloroform, were purchased from Aldrich with isotopic purities of
99.5%, 98% and 99.96%, respectively. The R-(+)-methoxy-trifluorornethylphenylacetyl
chloride ((R)-Mosher acid chloride, optical purity 98% and GC assay 98%), the 4dirnethylarninopyridine (DMAP) and the triethylamine (TEA), reagent grades (>99%
purity), were purchased from Aldrich.
Analytical Conditions
All reactions were monitored by gas chromatography, using a Hewlett-Packard
5890 Series I1 gas chromatography equipped with a flame ionization detector. The
column used was a HP-5, J&W Scientific, 30 rn x 0.32 mm. The chromatographic
conditions were: split mode inlet (250:I),250 "C; column temperature 60 - 175 OC at 3
"Urnin, He flow 30 mumin, 15 psi; detector 250 "C; 10 p1 injection.
The GC-MS analyses were performed on HP 5890 GC system equipped with an
HP 5971A Mass Selective Detector and a 70 eV electron-impact ion source.

The enantiomeric purity of the crude citronellol was measured using a RTBetaDEXsa 30 m x 0.32 mm ID x 0.25 mm obtained from Restek, Bellefonte, PA. The
chromatographic conditions were: split mode inlet (50:1), 150 "C; isothermal 80 "C, He
flow 30 mumin, 15 psi, 120 min; detector 150 "C; 10 p1 injection.
The diastereomeric purity of the Mosher ester of citronellol was determined on a
Hewlett-Packard 1050 Series high performance liquid chromatography (HPLC). The
column used was Chiralcel OJ-H, 250 mm x 4.6 mm obtained from Daicel Chemical
Industries, Fort Lee, NJ. The mobile phase was a mixture of HPLC grade hexanesethyl
alcohol, 90:lO to 50:50,0.6 mVmin, 20 minute gradient; room temperature; 210 and 220
nm. The diastereomeric excess was calculated based on HPLC area percent of the RMosher-R-citronellyl ester and R-Mosher-S-citronellyl ester. All products were
characterized using a 500 MHz Varian NMR equipped with Inova software in deuterated
chloroform (CDC13), except for the deuterated product d3-citronellol, which was
characterized using a 300 MHz Bruker NMR equipped with Topspin software.
Reaction Conditions
Asymmetric Transfer Hydrogenation

Unless specifically indicated, all reactions were performed in a 50 mL Schlenk
flask equipped with a teflon-coated magnetic stirrer bar. The reagents were added under a
continuous flow of argon while the flask was placed over a liquid nitrogen bath. The
reagents, 0.023 mmol [Ru(COD)Cl]., 0.046 mmol chiral ligand, 0.23 mmol substrate,
0.046 mmol KOH and 20 rnL isopropanol, were added in no particular order. The flask
was then sealed with a latex septum and subjected to three freeze-pump-thaw cycles using
vacuum and argon. The flask was then placed in a silicone oil bath at 100 OC while
116

under a slight overpressure of argon and as soon as the solvent started to boil, the reaction
system was closed and the mixture was stirred for 2 hours. At the end of the reaction,
the flask was removed from the oil bath and brought to room temperature before opening
to the atmosphere.

The isopropanol was removed under reduced pressure and the

reaction mixture was reconstituted with 2 mL of hexanes. Residual catalyst and solids
were removed by filtration through a silica gel plug using 0% to 5% ethyl acetate in
hexanes and the filtrate was concentrated to dryness under reduced pressure.
Derivatization with Mosher Acid Chloride
Same as in the Chiral Method Development Section.

Appendix
NMR Spectra
and
Chiral GC Chromatogram

Proton NMR of Citronellol Made by Asymmetric Transfer Hydrogenation

Carbon NMR of Citronellol Made by Asymmetric Transfer Hydrogenation

gCOSY NMR of Citronellol Made by Asymmetric Transfer Hydrogenation

Proton NMR of y-Geraniol

Carbon NMR of y-Geraniol

Proton NMR of Citronellol R-Mosher Ester (de by HPLC = 85% RR)

Proton NMR of p-Citronellol S-Naproxen Ester

Carbon NMR of !3-Citronellol S-Naproxen Ester

Proton NMR of S-Citronellol S-Naproxen Ester

Carbon NMR of S-Citronellol S-Naproxen Ester
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Proton NMR 1,2,2-trideuterium-3,7-dimethyloct-6-en-1-01
(d3-Citronellol)
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Carbon NMR of 1,2,2-trideuterium-3,7-dimethyloct-6-en-1-01
(d3-Citronellol)
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HMQC NMR of 1,2,2-trideuterium-3,7-dimethyloct-6-en-1-01
(d3-Citronellol)

Deuterium NMR of 1,2,2-trideuterium-3,7-dimethyloct-6-en-1-01
(d3Citronellol)

Chiral CG Chromatogram of S-Citronellol, R-Citronellol, Geraniol and Nerol

Chiral GC of Citronellol (ee > 98% R)
Data Pile C:\CHEM32\l\DATA\W-l-31-0B\MARIE_GC 2008-01-31 17-09-24\005P0501.D
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Acq. Inatr-nt

Injection Date
Acq. Method

:

HB

Seq. Line :

5
~ocationr vial 5
: 2/1/2008 1:16:14 AM
Inj :
1
Inj volume : External
: C:\Chem32\l\DATA\GMB-1-31-08\MARIE~GC2008-01-31 17-09-24\GLUTARIHIDE_
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